MCID: PLY014
MIFTS: 60

Polycystic Kidney Disease malady

Genetic diseases, Rare diseases, Nephrological diseases categories

Aliases & Classifications for Polycystic Kidney Disease

About this section

Aliases & Descriptions for Polycystic Kidney Disease:

Name: Polycystic Kidney Disease 10 68 45 23 12
Polycystic Kidney Diseases 47 65
Pkd 45 23
Polycystic Kidney and Hepatic Disease 1 10
Paroxysmal Kinesigenic Choreoathetosis 65
 
Polycystic Kidney - Body Part 65
Congenital Biliary Ectasias 10
Polycystic Renal Disease 23
Polycystic Kidneys 45


Classifications:



External Ids:

Disease Ontology10 DOID:898
ICD9CM29 753.1
SNOMED-CT59 111331000
MeSH36 D016767
NCIt42 C84619

Summaries for Polycystic Kidney Disease

About this section
NIH Rare Diseases:45 Polycystic kidney disease refers to a group of inherited kidney disorders characterized by the presence of multiple cysts in both kidneys. normal kidney tissue is replaced by fluid-filled sacs that interfere with the their ability to filter waste products from the blood. the growth of cysts causes the kidneys to become enlarged and can lead to kidney failure. cysts may also develop in other organs, particularly the liver. however, signs and symptom severity can vary greatly from person to person. treatment is tailored to the individual based upon their signs and symptoms.the two major forms of polycystic kidney disease are distinguished by the usual age of onset and their pattern of inheritance:(1) autosomal dominant polycystic kidney disease (adpkd) is the most common form that usually causes symptoms between the ages of 30 and 40; but they can begin earlier, even in childhood. adpkd can be further divided into type 1 and type 2, depending on the underlying genetic cause.(2) autosomal recessive polycystic kidney disease (arpkd) is a rare form that usually causes symptoms in infancy and early childhood and is often lethal early in life. some people with arpkd do not develop symptoms until later in childhood or even adulthood. last updated: 12/8/2011

MalaCards based summary: Polycystic Kidney Disease, also known as polycystic kidney diseases, is related to polycystic kidney disease 2 and polycystic liver disease. An important gene associated with Polycystic Kidney Disease is PKD1 (Polycystic Kidney Disease 1 (Autosomal Dominant)), and among its related pathways are Cargo trafficking to the periciliary membrane and Translation Translation regulation by Alpha-1 adrenergic receptors. Affiliated tissues include the kidney, kidney and liver, and related mouse phenotypes are respiratory system and liver/biliary system.

Disease Ontology:10 An autosomal dominant disease characterized by the presence of multiple cysts located in the kidney resulting from ciliopathy that disrupts the function of primary cilium.

Genetics Home Reference:23 Polycystic kidney disease is a disorder that affects the kidneys and other organs. Clusters of fluid-filled sacs, called cysts, develop in the kidneys and interfere with their ability to filter waste products from the blood. The growth of cysts causes the kidneys to become enlarged and can lead to kidney failure. Cysts may also develop in other organs, particularly the liver.

Wikipedia:68 Polycystic kidney disease (PKD or PCKD, also known as polycystic kidney syndrome) is a genetic disorder... more...

Related Diseases for Polycystic Kidney Disease

About this section

Diseases in the Polycystic Kidney Disease family:

Polycystic Kidney Disease 2 Polycystic Kidney Disease, Adult Type I
Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Type 3

Diseases related to Polycystic Kidney Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 352)
idRelated DiseaseScoreTop Affiliating Genes
1polycystic kidney disease 231.4HAX1, PKD1, PKD1L3, PKD2, PKD2L1, PKD2L2
2polycystic liver disease30.9PKD1, PKD2, PKHD1, PRKCSH
3autosomal genetic disease30.6PKD1, PKD2, PKHD1, TSC2
4kidney cancer30.4MTOR, TSC1, TSC2
5polycystic kidney and hepatic disease30.4HNF1B, IFT88, PKD1, PKD2, PKHD1, PRKCSH
6lymphangioleiomyomatosis30.0MTOR, TSC1, TSC2
7kidney disease11.6
8polycystic kidney disease, autosomal dominant10.9
9cystic kidney10.9
10primary hyperoxaluria10.9
11urinary system disease10.9
12autosomal dominant disease10.9
13aneurysm10.8
14hepatitis10.8
15polycystic kidney disease, adult type i10.7
16congenital hepatic fibrosis10.7
17renal hypertension10.6
18liver disease10.6
19endotheliitis10.6
20intracranial aneurysm10.6
21glomerular disease10.6
22chronic kidney failure10.6
23tuberous sclerosis10.6
24pain disorder10.6
25hajdu-cheney syndrome10.5
26end stage renal failure10.5
27peritonitis10.5
28hypertension, essential10.5
29mouth disease10.5
30polycystic kidney disease, type 310.5
31renal cell carcinoma10.5
32nephrolithiasis10.5
33adjustment disorder10.5
34impaired renal function disease10.5
35chronic interstitial cystitis10.5
36cystic fibrosis10.4
37orofaciodigital syndrome i10.4
38nephronophthisis10.4
39non-suppurative otitis media10.4
40polycystic kidney disease, infantile severe, with tuberous sclerosis10.4
41glomerulonephritis10.4
42aortic aneurysm10.4
43situs inversus10.3
44nephrotic syndrome10.3
45physical disorder10.3
46pyelonephritis10.3
47retinitis10.3
48chronic pain10.3
49autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis10.3
50dengue disease10.3

Graphical network of the top 20 diseases related to Polycystic Kidney Disease:



Diseases related to polycystic kidney disease

Symptoms for Polycystic Kidney Disease

About this section

Drugs & Therapeutics for Polycystic Kidney Disease

About this section

Drugs for Polycystic Kidney Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 97)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Sirolimusapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 1174253123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
2
Miconazoleapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 1291222916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
Desenex
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Makesense
Micantin (nitrate)
Micatin
 
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Oravig
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
Rash Relief Antifungal
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
3
EverolimusapprovedPhase 4, Phase 3, Phase 2, Phase 11742159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
Afinitor Disperz
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
VOTUBIA
Zortress
everolimus
4
CandesartanapprovedPhase 4, Phase 2144139481-59-72541
Synonyms:
139481-59-7
2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl] methyl]-3H-benzoimidazole-4-carboxylic acid
2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benzimidazole-7-carboxylic acid
2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl}-1H-benzimidazole-7-carboxylic acid
2-ethoxy-3-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]-3h-benzoimidazole-4-carboxylic acid
2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
2-ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole
AC-203
AC1L1DWT
Amias
Atacand
Atacand, Blopress, Amias, Ratacand,Candesartan
BIDD:GT0350
Blopress
Blopress (TN)
C07468
C081643
C24H20N6O3
CHEBI:216848
CHEBI:3347
 
CHEMBL1016
CID2541
CV 11974
CV-11974
CV11974
Candesartan
Candesartan (USAN/INN)
Candesartan Cilexetil
Candesartan [BAN]
Candesartan [USAN:INN]
Candesartan cilexetil
D00522
DB00796
FT-0083585
HMS2089M22
HSDB 7520
I01-0374
KS-5003
L000156
LS-32740
MolPort-003-845-570
MolPort-005-943-739
NCGC00167474-01
Ratacand
S1578_Selleck
TL8000897
UNII-S8Q36MD2XX
candesartan
5Calcium, DietaryPhase 4, Phase 3, Phase 23529
6Angiotensin II Type 1 Receptor BlockersPhase 4, Phase 3928
7
Angiotensin IIPhase 4, Phase 3, Phase 298568521-88-0, 11128-99-7172198
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
Ang II
Angiotensin 2
Angiotensin II (human)
 
Angiotensin II (mouse)
Angiotonin
Asp-arg-val-TYR-ile-his-pro-phe
Human angiotensin II
Hypertensin
Ile(5)-angiotensin II
8
CurcuminPhase 4120458-37-7969516
Synonyms:
1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione
1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
1,9-Bis(4-hydroxy-3-methoxyphenyl)-2,7-nonadiene-4,6-dione
C.I. Natural Yellow 3
CI Natural Yellow 3
Cucurmin
Curcuma
Curcumin
Curcumin I
Diferaloylmethane
Diferuloylmethane
Gelbwurz
Golden seal
Haidr
Halad
Haldar
Halud
Hydrastis
 
Indian saffron
Indian turmeric
Kacha haldi
Kurkumin [czech]
Merita earth
Natural yellow 3
Orange root
Safran D'inde
Souchet
Terra merita
Tumeric yellow
Turmeric
Turmeric (>98% curcurmin)
Turmeric oleoresin (79%-85% curcumin)
Turmeric yellow
Yellow ginger
Yellow puccoon
Yellow root
Yo-kin
Zlut prirodni 3 [Czech]
9
CilnidipinePhase 4, Phase 28132203-70-45282138
Synonyms:
(+-)-(E)-Cinnamyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl (2E)-3-phenyl-2-propenyl ester
132203-70-4
2-methoxyethyl (2E)-3-phenylprop-2-en-1-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
3-O-(2-methoxyethyl) 5-O-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
AC-270
AC1NQZJB
Atelec
Atelec (TN)
BRD-A07875874-001-01-6
Bio-0164
C1493_SIGMA
C27H28N2O7
CHEBI:31399
CHEBI:438069
CHEMBL452076
CID5282138
 
Cilnidipine (JAN/INN)
Cilnidipine [INN]
Cinaldipine
Cinalong
D01173
FRC 8653
FRC-8653
HMS2089J07
I06-0491
LS-131293
MolPort-003-845-950
NCGC00162150-01
NCGC00162150-02
NCGC00162150-03
S1293_Selleck
STK623341
Siscard
cilnidipine
10
Candesartan cilexetilPhase 4, Phase 2144145040-37-52540
Synonyms:
(+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)
1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
145040-37-5
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
2-ethoxy-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-benzoimidazole-4-carboxylic acid 1-cyclohe
AC-204
AC1L1DWQ
ATACAND HCT
Almirall brand of candesartan cilexetil
Amias
Astra brand of candesartan cilexetil
AstraZeneca brand of candesartan cilexetil
Atacand
Atacand (TN)
BRD-A65671304-001-02-6
BSPBio_002691
C07709
C077793
C33H34N6O6
CHEBI:216349
CHEMBL1014
CID2540
Candesartan cilexetil
Candesartan cilexetil (JAN/USAN)
Candesartan cilexetil [USAN]
Candesartan hexetil
D00626
FT-0082579
H212/91
 
HMS1922J09
HMS2093E20
I06-0090
KBio2_002187
KBio2_004755
KBio2_007323
KBio3_001911
KBioGR_001607
KBioSS_002187
Kenzen
L006257
LS-32741
MolPort-003-666-552
NCGC00095123-01
NCGC00095123-02
NCGC00095123-03
Parapres
Promed brand of candesartan cilexetil
Racanda
SPBio_000349
SPECTRUM1504261
ST51052687
Spectrum2_000485
Spectrum3_000996
Spectrum4_001124
Spectrum5_001462
Spectrum_001707
TCV 116
TCV-116
TL8000995
Takeda brand of candesartan cilexetil
UNII-R85M2X0D68
candesartan cilexitil
11
HydrochlorothiazideapprovedPhase 337558-93-53639
Synonyms:
125727-50-6
3,4-Dihydro-6-chloro-7-sulfamyl-1,2, 4-benzothi
3,4-Dihydrochlorothiazide
58-93-5
6-Chloro-7-sulfamoyl-3, 4-dihy
8049-49-8
AB00052012
AC-11072
AC1L1GDT
AC1Q55FM
AF-614/30832002
AKOS000121373
ARONIS24316
Acesistem
Acuilix
Acuretic
Aldactazide
Aldactazide 25/25
Aldazida
Aldectazide 50/50
Aldoril
Ambap58-93-5
Apo-Hydro
Apresazide
Aquarills
Aquarius
Aquazide H
Aquazide-H
BAS 00371709
BIDD:GT0153
BPBio1_000019
BRD-K13078532-001-05-2
BRN 0625101
BSPBio_000017
BSPBio_002132
Bio-0714
Bremil
Briazide
C7H8ClN3O4S2
CAS-58-93-5
CCRIS 2082
CHEMBL435
CID3639
CPD000035778
Caplaril
Capozide
Carozide
Catiazida
Chlorizide
Chlorosulthiadil
Chlorothiazide
Chlorsulfonamidodihydrobenzothiadiazine dioxide
Chlorzide
Chlothia
Cidrex
Clorana
Component of Butizide Prestabs
Concor Plus
Condiuren
D00340
D006852
DB00999
Diaqua
Dichlorosal
Dichlorotride
Dichlothiazide
Dichlotiazid
Dichlotride
Diclotride
Dicyclotride
Didral
Dihydran
Dihydrochlorothiazid
Dihydrochlorothiazide
Dihydrochlorothiazidum
Dihydrochlorurit
Dihydrochlorurite
Dihydroxychlorothiazidum
Direma
Disalunil
Disothiazid
Diu 25 Vigt
Diu-Melusin
Diu-melusin
Diuril
Diurogen
DivK1c_000289
Dixidrasi
Drenol
Dyazide
EINECS 200-403-3
EU-0100614
Esidrex
Esidrix
Esidrix (TN)
Esimil
Esoidrina
FT-0082750
Fluvin
H 4759
H1274
H2910_SIAL
H4759_SIAL
HCT
HCT-Isis
HCTZ
HCZ
HMS1568A19
HMS1920D19
HMS2091L05
HMS500O11
HMS553N04
HSDB 3096
Hidril
Hidro-Niagrin
Hidrochlortiazid
Hidroclorotiazida
Hidroclorotiazida [INN-Spanish]
Hidroronol
Hidrosaluretil
Hidrotiazida
Hyclosid
Hydrex-semi
Hydril
Hydro Par
Hydro-Aquil
Hydro-D
Hydro-Diuril
Hydro-Saluric
Hydro-T
Hydro-chlor
HydroDIURIL
Hydrochlorat
Hydrochloro Thiazide
Hydrochlorot
Hydrochlorothiazid
Hydrochlorothiazide
Hydrochlorothiazide (JP15/USP/INN)
Hydrochlorothiazide Intensol
Hydrochlorothiazide [INN:BAN:JAN]
 
Hydrochlorothiazidum
Hydrochlorothiazidum [INN-Latin]
Hydrochlorthiazide
Hydrochlorthiazidum
Hydrocot
Hydrodiuretic
Hydrodiuril
Hydropres
Hydrosaluric
Hydrothide
Hydrozide
Hydrozide Injection, Veterinary
Hypothiazid
Hypothiazide
Hytrid
Hyzaar
I09-0531
IDI1_000289
Idroclorotiazide
Idroclorotiazide [DCIT]
Idrotiazide
Inderide
Inderide 80/25
Indroclor
Ivaugan
Jen-Diril
KBio1_000289
KBio2_001357
KBio2_003925
KBio2_006493
KBio3_001352
KBioGR_000351
KBioSS_001357
LS-243
Lopac-H-4759
Lopac0_000614
Lopressor HCT
Lotensin HCT
Lotensin Hct
MLS000069619
Manuril
Maschitt
Maxzide
Maybridge Compound 10
Maybridge1_004336
Mazide 25 mg
Medozide
Megadiuril
Microzide
Microzide (TN)
Mictrin
Mikorten
Modurcen
Moduretic
MolPort-000-144-465
NCGC00015508-01
NCGC00015508-02
NCGC00015508-03
NCGC00015508-07
NCGC00015508-12
NCGC00021906-03
NCGC00021906-04
NCGC00021906-05
NCGC00021906-06
NCGC00021906-07
NCGC00021906-08
NCI-C55925
NCI60_004317
NINDS_000289
NSC 53477
NSC53477
Natrinax
Nefrix
Nefrol
Neo-Codema
Neo-Flumen
Neo-Minzil
Neo-codema
Neoflumen
Newtolide
Novodiurex
Oprea1_357174
Oretic
Pantemon
Panurin
Prestwick0_000009
Prestwick1_000009
Prestwick2_000009
Prestwick3_000009
Prestwick_263
Prinzide
Raunova Plus
Ro-Hydrazide
Ro-hydrazide
Roxane
S1708_Selleck
SAM002554901
SMR000035778
SPBio_001259
SPBio_001938
SPECTRUM1500335
STK315354
Saldiuril
Sectrazide
Selozide
Ser-Ap-Es
Servithiazid
Spectrum2_001040
Spectrum3_000456
Spectrum4_000006
Spectrum5_000824
Spectrum_000877
Spironazide
Su 5879
Tandiur
Thiaretic
Thiuretic
Thlaretic
Timolide
UNII-0J48LPH2TH
Unazid
Unipres
Urodiazin
Urozide
Vaseretic
Vetidrex
WLN: T66 BSWM EM DHJ HG ISZW
ZINC00896569
Ziac
Zide
adiazine-1,1-dioxide
component of Aldactazide
component of Aldoril
component of Caplaril
component of Cyclex
component of Dyazide
component of Esimil
diclot ride
dro-2H-1,2,4-benzothiadiazine 1,1-dioxide
hydrochlorothiazide
panurin dichloride
12
Metoprololapproved, investigationalPhase 318637350-58-64171
Synonyms:
(+/-)-Metoprolol
(RS)-Metoprolol
1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol
1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol
1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol
3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol
37350-58-6
51384-51-1
54163-88-1
AB00053499
AC-19022
AC1L1HKM
AstraZeneca Brand of Metaoprolol Tartrate
AstraZeneca Brand of Seloken
BRD-A03623303-045-02-0
Beatrolol
Beloc
Beloc Duriles
Beloc-Duriles
BelocDuriles
Betaloc
Betaloc Astra
Betaloc-Astra
BetalocAstra
Betalok
C07202
CCRIS 4198
CGP 2175
CGP-2175
CGP2175
CHEBI:6904
CHEMBL13
CID4171
D008790
D02358
DB00264
Dl-Metoprolol
Dutoprol
EINECS 253-483-7
EINECS 257-166-4
H 93 26
H 93-26
H 9326
HMS2090B15
 
HSDB 6531
I01-7125
I06-0125
Jsp006606
L000669
LOPRESSIDONE
LS-122450
Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate
Lopresor
Lopresoretic
Lopressor
Lopressor HCT
Meijoprolol
Metohexal
Metoprolol
Metoprolol (USAN/INN)
Metoprolol Succinate
Metoprolol Succinate extended-release
Metoprolol Tartrate
Metoprolol [USAN:INN:BAN]
Metoprolol succinate
Metoprolol tartrate
Metoprololum
Metoprololum [INN-Latin]
Metroprolol
MolPort-005-938-039
NCGC00021148-02
NCGC00021148-03
NCGC00021148-04
Novartis Brand of Metprolol Tartrate
Preblok
Prelis
Presolol
Selo-Zok
Seloken
Seloken AstraZeneca Brand
Selopral
Seroken
Spesicor
Spesikor
TOPROL-XL
Tartrate, Metoprolol
Toprol
Toprol XL
Toprol-XL
UNII-GEB06NHM23
dl-Metoprolol
metoprolol
13
MinoxidilapprovedPhase 33338304-91-54201
Synonyms:
16317-69-4
2,3-Dihydro-3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine
2,4-Diamino-6-piperidinilpirimidina-3-ossido
2,4-Diamino-6-piperidinilpirimidina-3-ossido [Italian]
2,4-Diamino-6-piperidino-pyrimidine-3-oxide
2,4-Diamino-6-piperidinopyrimidine 3-N-oxide
2,4-Diamino-6-piperidinopyrimidine 3-oxide
2,4-Pyrimidinediamine, 6-(1-piperidinyl)-, 3-oxide
2,6-Diamino-4-piperidinopyrimidin-1-oxid
3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine
3-hydroxy-2-imino-6-piperidin-1-ylpyrimidin-4-amine
38304-91-5
5-25-12-00317 (Beilstein Handbook Reference)
6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide
6-(piperidin-1-yl)pyrimidine-2,4-diamine 3-oxide
6-Amino-1,2-dihydro-1-hydroxy-2-imino-4-piperidinopyrimidine
6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide
6-Piperidino-2,4-diaminopyrimidine 3-oxide
6-[1-Piperidinyl]pyrimidine-2,4-diamine 3 oxide
AB00513797
AC-5271
AC1L1HN1
Alopexil
Alostil
Ambap38304-91-5
Apo-Gain
Apo-gain
BCBcMAP01_000193
BPBio1_000065
BRD-K06902185-001-05-2
BRD-K14888893-001-02-3
BRN 0886240
BSPBio_000059
BSPBio_001385
BSPBio_002037
Bio1_000084
Bio1_000573
Bio1_001062
Bio2_000105
Bio2_000585
Boost Regrowth For Women
Bosley Professional Strength Hair Regrowth Treatment Regular Strength For Men
Bosley Professional Strength Hair Regrowth Treatment Regular Strength For Women
C9H15N5.H2O
CAS-38304-91-5
CBiol_001798
CHEBI:49774
CHEBI:6942
CHEMBL609587
CHEMBL802
CID4201
CPD-7668
CPD000058963
Careone Hair Regrowth Treatment
Careone Hair Regrowth Treatment Extra Strength
Cerafill Retaliate
Cerafill Retaliate Extra Strength For Men
D00418
D008914
DB00350
DB08225
DivK1c_000160
EINECS 253-874-2
EU-0100786
Equaline Hair Regrowth Treatment For Men
Equaline Hair Regrowth Treatment For Women
Equaline Hair Regrowth Treatment for men
Equaline Hair Regrowth Treatment for women
Equate Hair Regrowth Treatment
Equate Hair Regrowth Treatment for men
Equate Hair Regrowth Treatment for women
Gen-Minoxidil
Good Neighbor Pharmacy Hair Regrowth Treatment For Men
Good Sense Hair Regrowth Treatment
Good Sense Hair Regrowth Treatment for Men
Good Sense Hair Regrowth Treatment for women
HMS1361F07
HMS1568C21
HMS1791F07
HMS1920P03
HMS1989F07
HMS2089L08
HMS2091F20
HMS500H22
HSDB 6538
Hair Regrowth Treatment
Hair Regrowth Treatment Extra Strength for Men
Hair Regrowth Treatment For Men
Hair Regrowth Treatment For Men Extra Strength
Hair Regrowth Treatment For Women
Hair Regrowth Treatment for women
Hair Regrowth treatment for men
Hair Regrowth treatment for women
Harmon Face Values Minoxidil
IDI1_000160
IDI1_033855
Image Essentials Hair Regrowth Treatment
Image Essentials Hair Regrowth Treatment For Men
Jsp006715
KBio1_000160
KBio2_000105
KBio2_001449
KBio2_002673
KBio2_004017
KBio2_005241
KBio2_006585
KBio3_000209
KBio3_000210
KBio3_001537
KBioGR_000105
KBioGR_000585
KBioSS_000105
KBioSS_001449
Keranique For Women Hair Regrowth Treatment
Kirkland Signature Minoxidil
LS-135040
Leader Hair Regrowth Treatment
Loesch Hair Regrowth Formula Unscented Topical Solution Extra-Strength for Men
 
Loniten
Loniten (TN)
Lonolox
Lopac-M-4145
Lopac0_000786
M 4145
M1389
MINOXIDIL (FOR MEN)
MINOXIDIL (FOR WOMEN)
MINOXIDIL EXTRA STRENGTH (FOR MEN)
MINOXIDIL EXTRA STRENGTH FOR MEN
MLS000028566
MLS000859953
MLS001077294
Men s Rogaine Foam
Men's Rogaine
Mens Comback Hair Regrowth Treatment Extra Strength Unscented
Mens Hair Regrowth Treatment extra strength
Mens Kirkland Extra Strength
Mens Rogaine Extra Strength
Mens Rogaine Foam
Mens Rogaine Unscented Formula
Minodyl
Minossidile
Minossidile [Italian]
Minoxidil
Minoxidil (USP/INN)
Minoxidil Foam
Minoxidil For Women
Minoxidil Form Men extra strength
Minoxidil Pfizer Brand
Minoxidil [USAN:BAN:INN]
Minoxidil for men
Minoxidil for women
Minoxidil regular strength
Minoxidilum
Minoxidilum [INN-Latin]
Minoxigaine
Minoximen
MolPort-003-666-236
MolPort-005-932-694
NCGC00015673-01
NCGC00015673-02
NCGC00015673-04
NCGC00015673-11
NCGC00018278-01
NCGC00024666-01
NCGC00024666-02
NCGC00024666-03
NCGC00024666-04
NCGC00024666-05
NCGC00024666-06
NCGC00024666-07
NCGC00024666-08
NCGC00179672-01
NINDS_000160
Neoxidil
Nioxin Hair Regrowth Treatment Extra Strength For Men
Nioxin Hair Regrowth Treatment For Women
Normoxidil
Pantene Pro-v Expert Collection Hair Regrowth Treatment for Women
Pfizer Brand of Minoxidil
Pierminox
Prestwick0_000020
Prestwick1_000020
Prestwick2_000020
Prestwick3_000020
Prestwick_521
Prexidil
Pyrimidine, 2,4-diamino-6-piperidino-, 3-oxide
ROGAINE (FOR MEN)
ROGAINE (FOR WOMEN)
ROGAINE EXTRA STRENGTH (FOR MEN)
Re-gro
Regaine
Renewal For Men
RiUP
Riup (TN)
Rogaine
Rogaine (TN)
Rogaine Extra Strength for Men
Rogaine for Men
Rogaine for Women
Rogaine, Regaine, Avacor and Mintop, Minoxidil
S1383_Selleck
SAM002589949
SBB056986
SGCUT00112
SMP1_000192
SMR000058963
SMR000326812
SPBio_001006
SPBio_001980
SPECTRUM1500415
Simply Right Minoxidil
Simply Right Minoxidil extra strength
Solution
Spectrum2_001053
Spectrum3_000509
Spectrum4_000063
Spectrum5_001299
Spectrum_000969
TM-160
Theroxidil
Tocris-0583
Toppik Mens Hair Regrowth Treatment Extra Strength
Toppik Womens Hair Regrowth Treatment
Tricoxidil
Trocoxidil
U 10858
U-10,858
U-10858
Vanarex Hair Regrowth Treatment
Womens Rogaine - Unscented
Womens Rogaine Unscented
ZINC00001735
minoxidil
nchembio.79-comp10
to_000070
14
Octreotideapproved, investigationalPhase 3, Phase 219183150-76-9383414, 6400441
Synonyms:
(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-Aminobutyl)-19-((2-amino-3-phenylpropanoyl)amino)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-(hydroxymethyl)propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaa
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
79517-01-4 (acetate salt)
83150-76-9
AC1L1GVU
AC1L8LCD
AC1L9M4X
C07306
C5H12O2.C4H10
CHEBI:427278
CHEBI:611465
CHEMBL1680
CID383414
CID448601
CID54374
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide
D00442
DRG-0115
HMS2090C09
HS-2020
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R*
L000453
 
LS-177735
LS-187135
Longastatin
NCGC00181796-01
NCI60_025753
Ocphyl
Octreotida
Octreotida [Spanish]
Octreotide
Octreotide (USAN/INN)
Octreotide Acetate
Octreotide Acetate Salt
Octreotide [USAN:INN:BAN]
Octreotide acetate
Octreotide-LAR
Octreotidum
Octreotidum [Latin]
Octrotide
SAN 201-995
SM 201-995
SMS 201-995
SMS-201-995
Sandostatin
Sandostatine
Sandoz 201-995
UNII-RWM8CCW8GP
nchembio.184-comp3
zacycloicosane-4-carboxamide acetate
15
HydralazineapprovedPhase 34186-54-43637
Synonyms:
(1Z)-1(2H)-Phthalazinone hydrazone
(2H)-Phthalazinone hydrazone
1(2H)-Phthalazinone hydrazone
1(2H)-Phthalazinone, hydrazone
1-Hydrazinophthalazine
1-Phthalazinylhydrazine
304-20-1 (mono-hydrochloride)
5-25-17-00412 (Beilstein Handbook Reference)
6-Hydralazine
86-54-4
AC1L1GDN
AC1Q4UY1
AKOS000122609
Apresolin
Apresoline
Apressin
Apressin (pharmaceutical)
Apressoline
Aprezolin
BA 5968
BRD-K82103381-003-03-7
BRN 0132615
BSPBio_002130
C 5968
C-5068
C-5968
C07040
C8H8N4
CAS-304-20-1
CCRIS 5385
CHEBI:5775
CHEMBL276832
CID3637
Ciba 5968
D08044
DB01275
DivK1c_000117
EC-000.1838
EINECS 201-680-3
HLZ
Hidral
Hidral (TN)
Hidralazin
Hidralazina
Hidralazina [INN-Spanish]
Hidralazina [Spanish]
Hipoftalin
Hydralazin
Hydralazine
Hydralazine (INN)
Hydralazine Hydrochloride
Hydralazine [INN:BAN]
 
Hydralazine hydrochloride
Hydralazinum
Hydralazinum [INN-Latin]
Hydrallazin
Hydrallazine
Hydrazinophthalazine
Hydrazone 1(2H)-phthalazinone
Hypophthalin
IDI1_000117
Idralazina
Idralazina [DCIT]
Idralazina [Italian]
InChI=1/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)
KBio1_000117
KBio2_001355
KBio2_003923
KBio2_006491
KBio3_001350
KBioGR_000349
KBioSS_001355
LS-109171
Lopac-H-1753
Lopac0_000593
MolPort-000-876-738
MolPort-001-794-088
NCGC00015501-01
NCGC00015501-02
NCGC00015501-05
NCGC00162199-01
NCIOpen2_001484
NINDS_000117
NSC 126699
NSC126699
Oprea1_207681
Oprea1_416878
Phthalazin-1-ylhydrazine
Praparat 5968
Prestwick0_000169
Prestwick1_000169
Prestwick2_000169
SPBio_000977
SPBio_001958
ST50512087
Spectrum2_000969
Spectrum3_000455
Spectrum4_000005
Spectrum5_000822
Spectrum_000875
UNII-26NAK24LS8
WLN: T66 CNNJ BMZ
ZINC12360535
[2H-Phthalazin-(1Z)-Ylidene]-Hydrazine Hydrochloride
hydralazine
phthalazin-1-ylhydrazine
16
Telmisartanapproved, investigationalPhase 3253144701-48-465999
Synonyms:
144701-48-4
2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid
4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid
4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid
4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
AC-2013
AC1L24EB
AC1Q5U7O
Abbott brand of telmisartan
BAY-68-9291
BAY68-9291
BIBR 277
BIBR 277SE
BIBR-277
BIBR-277-SE
BIBR-277SE
BIDD:GT0365
BRD-K73999723-001-02-2
BSPBio_002738
Bay 68-9291
Bio-0103
Boehringer Ingelheim brand of telmisartan
C07710
C084178
C33H30N4O2
CHEBI:9434
CHEMBL1017
CID65999
CPD000466326
D00627
DB00966
Glaxo Wellcome brand of telmisartan
 
GlaxoSmithKline brand of telmisartan
HMS1922P07
HMS2051P16
HMS2090P17
HMS2093M22
HSDB 7590
I06-0281
KBio3_001958
KBioGR_001842
Kinzal
Kinzalmono
L001035
LS-44263
MLS000759432
MLS001076687
Micardis
Micardis (TN)
Micardis, Targit, Temax, BIBR277, Telmisartan
MolPort-003-666-621
NCGC00095150-01
NCGC00095150-02
NCGC00095150-03
Pritor
S1738_Selleck
SAM001246602
SMR000466326
SPBio_002131
SPECTRUM1505261
STK624049
Spectrum2_001976
Spectrum3_001089
Spectrum4_001261
Spectrum5_001053
TL8000991
Telmisartan
Telmisartan (JAN/USAN/INN)
Telmisartan [USAN:INN]
UNII-U5SYW473RQ
YM-086
17
DiltiazemapprovedPhase 36842399-41-739186
Synonyms:
(+)-cis-5-[2-(dimethylamino)Ethyl]-2,3-dihydro-3-hydroxy-2-(P-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester
(+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester
(2S,3S)-5-(2-(dimethylamino)Ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate
(2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate
(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate
(2S,3S)-5-[2-(dimethylamino)ethyl]-2-[4-(methyloxy)phenyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate
(2S-cis)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one
(2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one
144604-00-2
33286-22-5
42399-41-7
AC-936
AC1L2181
AC1Q6LHX
Acalix
Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
Adizem
Aldizem
Altiazem
Anginyl
Angizem
Anoheal
Apo-Diltiaz
BIDD:GT0548
BPBio1_000230
BRD-K24023109-001-02-5
BRD-K24023109-003-03-9
BRN 3573079
BSPBio_000208
BSPBio_001311
Bio1_000371
Bio1_000860
Bio1_001349
Britiazim
Bruzem
C06958
C22H26N2O4S
CHEBI:101278
CHEMBL23
CID39186
Calcicard
Cardil
Cardizem
Cardizem (Hydrochloride)
Cardizem CD
Cardizem SR
Cardizen LA
Cartia XT
Citizem
Cormax
D-cis-Diltiazem
D07845
DB00343
Deltazen
Dilacor
Dilacor-XR
Diladel
Dilcontin
Dilpral
 
Dilren
Dilrene
Dilt-cd
Dilta-Hexal
Diltia
Diltiazem
Diltiazem (INN)
Diltiazem Hydrochloride
Diltiazem [INN:BAN]
Diltiazem hydrochloride
Diltiazemum
Diltiazemum [INN-Latin]
Dilticard
Diltzac
Dilzem
Dilzen
EINECS 255-796-4
Endrydil
FT-0081415
HMS1791B13
HMS1989B13
HMS2089H09
HSDB 6528
Herbesser
Incoril AP
LS-40510
Lopac0_000327
MK-793 (Malate)
Masdil
MolPort-002-509-369
NCGC00024309-02
NCGC00024309-04
NCGC00024309-05
NCGC00024309-06
NCGC00024309-07
NCGC00024309-08
NCGC00024309-09
NCGC00024309-10
Novo-Diltazem
Nu-Diltiaz
Prestwick0_000134
Prestwick1_000134
Prestwick2_000134
Prestwick3_000134
RG 83606 (Hydrochloride)
SPBio_002147
STOCK1N-03672
Surazem (TN)
Syn-Diltiazem
Tiamate
Tiazac
Tiazac Tildiem
Tiazac XC
Tocris-0685
UNII-EE92BBP03H
Viazem
[(2S,3S)-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate
d-cis-Diltiazem
diltiazem
nchembio.368-comp1
18
Lisinoprilapproved, investigationalPhase 311283915-83-75362119
Synonyms:
(2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline
76547-98-3
77726-95-5
83915-83-7 (Parent)
AC1NSFPF
Acerbon
Acercomp
Alapril
BB_NC-1454
BIDD:GT0755
BPBio1_000290
BRD-K67966701-335-03-5
BRN 4276619
BSPBio_000262
C21H31N3O5
CCRIS 3568
CHEBI:43755
CHEMBL1237
CID5362119
Carace
Cipral
Cipril
Coric
D08131
DB00722
DivK1c_001037
Doneka
EINECS 278-488-1
HMS1921B14
HMS2090O14
HMS2092L21
HMS503O15
I06-1895
ICI-209K
IDI1_001037
Inhibril
Inopril
KBio1_001037
KBio2_000977
KBio2_003545
KBio2_006113
KBio3_002002
KBioGR_001599
KBioSS_000977
L0220
LPR
LS-118899
Linopril
Linvas
Lipril
Lisinal
Lisinopril
Lisinopril (INN)
 
Lisinopril (anhydrous)
Lisinopril 10mg
Lisinopril 2.5mg
Lisinopril 20mg
Lisinopril 40mg
Lisinopril 5mg
Lisinopril Dihydrate
Lisinopril anhydrous
Lisinoprilum
Lisinoprilum [Latin]
Lisipril
Lisoril
Lispril
Longes
Loril
Lysinopril
MK 521
MK 522
MK-521
MLS001306436
MLS001306481
MolPort-002-507-428
N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
N-(1(S)-Carboxy-3-phenylpropyl)-L-lysyl-L-proline
N2-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl-L-proline
N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
NCGC00179623-01
NINDS_001037
Noperten
Novatec
Presiten
Prestwick0_000301
Prestwick1_000301
Prestwick2_000301
Prestwick3_000301
Prinil
Prinivil
Prinzide
Renacor
SMR000544473
SPBio_001351
SPBio_002481
SPECTRUM1501217
Sinopril
Sinopryl
Spectrum2_001456
Spectrum3_000941
Spectrum4_001040
Spectrum5_000995
Spectrum_000497
TL8005499
Tensopril
Tensyn
Tersif
Vivatec
Zestoretic
Zestril
Zestril (TN)
[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE
[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline
lisinopril
19
MetforminapprovedPhase 3, Phase 1, Phase 01573657-24-9, 1115-70-414219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMBG
DMGG
Diabefagos
Diabetosan
Diabex
Diaformin
Dianben
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Meguan
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin Hydrochloride
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
Obimet
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
20
ClonidineapprovedPhase 31774205-90-72803
Synonyms:
1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- (9CI)
2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
2,6-dichloro-N-(2-imidazolidinylidene)aniline
2,6-dichloro-N-2-imidazolidinylidenebenzenamide
2,6-dichloro-N-imidazolidin-2-ylideneaniline
2-((2,6-Dichlorophenyl)imino)imidazolidine
2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2)
2-(2,6-Dichloroanilino)-2-imidazoline
2-(2,6-Dichlorophenylamino)-2-imidazoline
2-(2,6-Dichlorophenylimino)imidazolidine
2-Imidazoline, 2-(2,6-dichloroanilino)- (7CI,8CI)
2-[(2,6-Dichlorophenyl)imino]imidazoline
2-[(2,6-dichlorophenyl)imino]-2-imidazoline
4205-90-7
4205-91-8 (mono-hydrochloride)
57066-25-8
734571A
AB00514634
AC1L1EI5
AC1Q3K6V
AKOS001595470
Adesipress
BIDD:GT0547
BPBio1_000040
BRD-K98530306-001-02-1
BRD-K98530306-003-05-0
BSPBio_000036
BSPBio_001588
BSPBio_002055
Bio1_000470
Bio1_000959
Bio1_001448
Bio2_000308
Bio2_000788
C9H9Cl2N3
CAS-4205-91-8
CATAPRES-TTS-1
CATAPRES-TTS-2
CATAPRES-TTS-3
CCRIS 7787
CHEBI:3757
CHEBI:46632
CHEMBL134
CID2803
Catapres
Catapres- TTS
Catapres-TTS
Catapresan
Catapressan
Catarpres
Catarpres-TTS
Catarpres-TTS (TN)
Catarpresan
Chlofazoline
Chlornidinum
Clofenil
Clonidin
Clonidina
Clonidina [INN-Spanish]
Clonidine
Clonidine (JAN/USAN/INN)
Clonidine HCl
Clonidine Hydrochloride
Clonidine Transdermal System
Clonidine [USAN:BAN:INN]
Clonidinhydrochlorid
Clonidinum
Clonidinum [INN-Latin]
Clonistada
Clopheline
D00281
DB00575
DB07566
DivK1c_000774
 
Dixarit
Duraclon
Duraclont
EINECS 224-119-4
Gemiton
HMS1361P10
HMS1791P10
HMS1989P10
HMS2089G11
HSDB 3040
Hemiton
IDI1_000774
IDI1_034058
Ipotensium
Isoglaucon
KBio1_000774
KBio2_000308
KBio2_001821
KBio2_002876
KBio2_004389
KBio2_005444
KBio2_006957
KBio3_000615
KBio3_000616
KBio3_001275
KBioGR_000308
KBioGR_001572
KBioSS_000308
KBioSS_001821
Kapvay
Klofelin
Klofenil
L000193
LS-79606
Lopac-C-7897
Lopac0_000268
M 5041T
M-5041T
MolPort-001-779-668
MolPort-005-932-374
N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
NCGC00015268-01
NCGC00015268-02
NCGC00015268-08
NCGC00024734-01
NCGC00024734-02
NCGC00024734-03
NCGC00024734-04
NCGC00024734-05
NCGC00179680-01
NINDS_000774
Nexiclon
Nexiclon Xr
Prestwick0_000248
Prestwick1_000248
Prestwick2_000248
Prestwick3_000248
SKF 34427
SPBio_001233
SPBio_002255
ST 155BS
ST-155-BS
ST-155BS
Spectrum2_001187
Spectrum3_000358
Spectrum4_000956
Spectrum5_000759
Spectrum_001341
T171
Tenso-Timelets
Tocris-0690
UNII-MN3L5RMN02
ZINC00896484
clonidine
nchembio.79-comp11
nchembio705-10
21
PravastatinapprovedPhase 314281093-37-054687
Synonyms:
(+)-(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8ar)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acid
(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid
(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid
3beta-Hydroxycompactin
81093-37-0
81131-70-6 (hydrochloride salt)
AC1L1HJL
AC1Q5T3M
BIDD:GT0773
BRD-K60511616-236-01-4
C01844
C23H36O7
CCRIS 7557
CHEMBL1144
CID54687
Compactin
D08410
DB00175
Elisor
Eptastatin
FT-0082682
KS-5015
LS-94713
Lipostat
Mevalothin
Mevalotin
Mevastatin
Mevinolin
Oliprevin
 
Pravachol
Pravaselect
Pravastatin
Pravastatin (INN)
Pravastatin Sodium
Pravastatin Sodium Salt
Pravastatin [INN:BAN]
Pravastatin acid
Pravastatin sodium
Pravastatin tert-Octylamine Salt
Pravastatina
Pravastatina [Spanish]
Pravastatine
Pravastatine [French]
Pravastatinum
Pravastatinum [Latin]
Pravator
Pravator (TN)
RMS-431
SQ-31,000
Selectin
Selektine
Selipran
UNII-KXO2KT9N0G
Vasten
nchembio.301-comp7
nchembio790-comp15
pravastatin
pravastatina
pravastatine
pravastatinum
22
BenzocaineapprovedPhase 2, Phase 315361994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
20/20 Topical Anesthetic
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Alcohol Prep Pads
Allegenal-m
Alpha-caine Topical Anesthetic
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anbesol Jr
Anbesol Maximum Strength
Anbesol Regular Strength
Anestenka
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthetic
Anesthone
Atopalm Oral Pain Relief
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Baby Anestenka
Baby Sensigel
Baby Sensigel Night Time Formula
Baby Teething Oral Pain Reliever
Bactimicina For Sore Throat
Bencocaine Topical Anesthetic
Bensokain
Benz O Sthetic
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzodent
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
Boil Ease
Boy Butter Desensitizing Lubricant
Boy Butter Extreme Desensitizing Lubricant
Boy Butter Extreme H2O Desensitizing Lubricant
Brace Relief
Budpak Baby Teething Oral Pain Reliever
Budpak Oral Maximum Strength
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Carmex Cold Sore Treatment External Analgesic
Caswell No. 430A
Cepacol Fizzlers
Cepacol Sensations Hydra
Cepacol Sensations Sore Throat Hydra citrus splash
Cepacol Sensations Warming
Certus Sting Relief Prep Pad
Chloraseptic
Chloraseptic Warming Sore Throat
Colgate Orabase
Comfortcaine Topical Anesthetic
Cvs Fast Acting Baby Teething
Cvs Maximum Strength
Cvs Maximum Strength Boil Relief
Cvs Oral Anesthetic
Cvs Pharmacy Instant Toothache
Cvs Pharmacy Maximum Strength
Cvs Pharmacy Mouth Sore Gel
Cvs Pharmacy Nighttime Oral Pain Relief
D001566
D00552
DB01086
Dental Relief
Dentek Instant Pain Relief Maximum Strength
Dermoplast
Diet Ayds
DivK1c_000932
Dollar General Toothache Relief
Dukal Sting Relief Pad
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Finafta Baby
Finafta MultiOral
Formate, Benzocaine
Gelato Topical Anesthetic
Good Neighbor Pain Relief
Goodsense Oral Pain Relief
Gps Topical Anesthetic
Gumnumb Topical Anesthetic
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Heb Severe Toothache
Herbasoul Male Genital Desensitizer Cream
 
Hurricaine
Hurricaine Topical Anesthetic
Hurricaine Topical Anesthetic Gel
Hurricaine Topical Anesthetic Liquid
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
Insect Bite Relief
Instant Toothache Pain Relief
Intense Cvs Intense Toothache
Iodent Maximum Strength Oral Analgesic
Ismile Topical Anesthetic
Jianze Sting Relief Pads
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Kank-a Mouth Pain
Keloform
Kmart Smart Sense
Kroger Toothache Pain Relief
LS-35847
Leader Oral Analgesic
Little Colds Sore Throat Relief Melt Aways
MLS001331704
MLS002153970
Makesense Junior Pain Relief
Makesense Pain Relief
Male Desensitizer Pleasure Balm
Mandelay Male Genital Desensitizer
Mark 3
Methanesulfonate, Benzocaine
MolPort-000-871-526
Mouth Sore Medication
Mouth Sore Relief Applicator
Mouth Sore Relief Professional Strength
My Fair Baby Instant Pain Relief
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Nene Dente
Norcain
Norcaine
Norcainum
Opahl
Opahl Dye Free
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orajel For All Mouth Sores Maximum Strength
Orajel For Cold Sores
Orajel For Toothache Maximum Strength
Orajel Instant Pain Relief Maximum Strength
Orajel Instant Pain Relief Regular Strength
Orajel Instant Relief For Teething Pain
Orajel Instant Relief For Teething Pain Cooling Cucumber
Orajel Instant Relief For Teething Pain Daytime Nighttime Twin Pack
Orajel Instant Relief For Teething Pain Longer Lasting
Orajel Maximum Strength
Orajel Nighttime Instant Relief For Teething Pain Longer Lasting Extra Strength
Orajel Severe Toothache Maximum Strength Fast-Acting Formula
Oral Analgesic Maximum Strength
Oral B Instant Pain Relief
Oral Gel Maximum Strength
Oral Pain Relief Anesthetic Anesthetic
Oral Pain Reliever
Oralabs Cold Sore Treatment
Orthesin
Otocain
Outgro
Pac-dent Top Gel
Pain Relief
Pain Relief Alcohol Swabs
Parathesin
Parathesin (TN)
Parathesine
Physicians Care Sting Relief Pad
Pleasure Balm Kama Sutra
Preboost
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
Purelife Topical Anesthetic
Quality Choice Maximum Strength Oral Pain Relieving
Red Cross Oral Pain Relief
Rexall Maximum Strength
Rite Aid Baby Care
Rite Aid Liquid Anesthetic Oral Pain Relief
Rite Aid Maximum Strength
Rite Aid Oral Pain Reliever
Rite Aid Professional Strength
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Sally Hansen Ouch-relief Numbing Wipes
Sally Hansen Ouch-relief Wax Kit
Sally Hansen Ouch-relief Wax Strip Kit
Sensigel
Severe Oral Pain Reliever
Sheffield Baby Teething Gel
Sheffield Pain Relief
Shunga Male Genital Desensitizer
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Sting Relief Medicated Pad
Sting Relief Pads
Tanac
Terrasil Boil Pain Relief
Tiger Supply Inc Topical Anesthetic
Top Quality Mfg. Topical Anesthetic
Topcaine
Topcare Maximum Strength
Topical Anesthetic Banana
Topical Anesthetic Bubble Gum
Topical Anesthetic Cherry
Topical Anesthetic Mint
Topical Anesthetic Pina Colada
Topical Anesthetic Raspberry
Topical Anesthetic Strawberry
UNII-U3RSY48JW5
Ultracare Anesthetic Bubble Gum
Ultracare Anesthetic Butter Rum
Ultracare Anesthetic Creme de Menthe
Ultracare Anesthetic Pina Colada
Ultracare Anesthetic Walterberry
WLN: ZR DVO2
Walgreens Baby Teething
Walgreens Intense Toothache
Walgreens Maximum Strength
Walgreens Pain Relieving For Boils
Walgreens Severe Oral Pain Reliever
Walgreens Severe Toothache Relief
Winco Foods Maximum Strength Oral Analgesic
ZINC12358719
Zilactin-b
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
23Insulin, Globin ZincPhase 34069
24Arginine VasopressinPhase 2, Phase 3163
25VasopressinsPhase 2, Phase 3159
26insulinPhase 34069
27
SomatostatinPhase 3, Phase 214151110-01-153481605
Synonyms:
growth hormone-inhibiting hormone (GHIH)
 
somatotropin release-inhibiting factor (SRIF)
somatotropin release-inhibiting hormone
28
LactitolPhase 3313585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
29AngiopeptinPhase 2, Phase 366
30lanreotidePhase 2, Phase 366
31Metoprolol succinatePhase 3186
32TriptolidePhase 3638748-32-2
33tannic acidNutraceuticalPhase 2, Phase 31536
34
Nitric OxideapprovedPhase 2, Phase 154010102-43-9145068
Synonyms:
(.)NO
(NO)(.)
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous Nitrate Vasodilator
Endothelium-Derived Nitric Oxide
HNO
HSDB 1246
INOmax
INOmax (TN)
Inomax
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, Mononitrogen
Monoxide, Nitrogen
Monoxido de nitrogeno
Monoxyde d'azote
NITRIC-OXIDE
NO
NO(.)
Nitrate Vasodilator, Endogenous
Nitric Oxide, Endothelium Derived
 
Nitric Oxide, Endothelium-Derived
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
OHM 11771
Oxide, Nitric
Oxido de nitrogeno(ii)
Oxido nitrico
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(II)-oxid
Stickstoff(ii)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, Endogenous Nitrate
[NO]
endothelium-derived relaxing factor
monoxido de nitrogeno
monoxyde d'azote
nitric oxide
nitrogen monooxide
nitrogen monoxide
nitrosyl
oxido de nitrogeno(II)
oxido nitrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
35
Ursodeoxycholic acidapproved, investigationalPhase 274128-13-231401
Synonyms:
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oate
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oic acid
(3a,5b,7b)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic acid
(3α,5β,7β)-3,7-dihydroxycholan-24-oic acid
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
128-13-2
17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol
3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid
3,7-Dihydroxycholan-24-oic acid
3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid
3-alpha,7-beta-Dihydroxycholanic acid
3-alpha,7-beta-Dioxycholanic acid
3a,7b-Dihydroxy-5b-cholan-24-oate
3a,7b-Dihydroxy-5b-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholanic acid
4-10-00-01604 (Beilstein Handbook Reference)
50809-41-1
5beta-Cholan-24-oic acid-3alpha,7beta-diol
5beta-Cholanic Acid-3alpha,7beta-diol
7-beta-Hydroxylithocholic acid
7beta-Hydroxylithocholic acid
80225-86-1
AB00513977
AC-18919
AC-2081
AC1L1LJH
Acide ursodesoxycholique
Acide ursodesoxycholique [INN-French]
Acido ursodeossicolico
Acido ursodeossicolico [Italian]
Acido ursodeoxicolico
Acido ursodeoxicolico [INN-Spanish]
Acidum ursodeoxycholicum
Acidum ursodeoxycholicum [INN-Latin]
Actigall
Actigall (TN)
Antigall
Arsacol
BB_NC-2372
BPBio1_001052
BRN 3219888
BSPBio_000956
C07880
C24H40O4
CCRIS 5502
CHEBI:9907
CHEMBL1551
CHEMBL73390
CID11516715
CID31401
CPD-10534
CPD000058403
Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)- (9CI)
Cholit-ursan
D00734
DB01586
Delursan
Deoxyursocholic Acid
Destolit
Deursil
Dom-ursodiol c
EINECS 204-879-3
HMS1570P18
ISO-URSODEOXYCHOLIC ACID
 
IU5
LMST04010033
LS-53033
Litursol
Lyeton
MLS000028461
MLS001066373
MolPort-001-794-630
MolPort-005-932-884
NCGC00179363-01
NCI60_028904
NSC 657950
NSC 683769
PHL-ursodiol c
PMS-ursodiol c
Peptarom
Prestwick0_000958
Prestwick1_000958
Prestwick2_000958
Prestwick3_000958
S1643_Selleck
SAM002264653
SMP2_000012
SMR000058403
SPBio_003105
Sodium Ursodeoxycholate
Solutrat
U-9000
U0030
U5127_SIGMA
UDCA
UDCS
UNII-724L30Y2QR
URSODEOXYCHOLIC ACID
UrSO
Urosdesoxycholate
Urosdesoxycholic acid
Urosiol
Ursacholic Acid
Ursacol
Urso
Urso (TN)
Urso 250
Urso DS
Urso Forte
Ursobilin
Ursochol
Ursodamor
Ursodeoxy cholic acid
Ursodeoxycholate
Ursodeoxycholic acid
Ursodeoxycholic acid (JP15/INN)
Ursodeoxycholic acid, UDCA, Ursosan, Ursofalk, Urso Forte, Udiliv, Ursodiol
Ursodeoxycholicacid
Ursodesoxycholic acid
Ursodexycholate
Ursodexycholic Acid
Ursodexycholic acid
Ursodiol
Ursodiol (USP)
Ursodiol Tablets, 250 mg
Ursodiol Tablets, 500 mg
Ursodiol [USAN]
Ursofalk
Ursolvan
Ursosan
chenodeoxycholic acid
ursodeoxycholate
ursodiol
36
Niacinapproved, investigational, nutraceuticalPhase 234059-67-6938
Synonyms:
3-Carboxylpyridine
3-Carboxypyridine
3-Pyridinecarboxylate
3-Pyridinecarboxylic acid
3-Pyridylcarboxylate
3-Pyridylcarboxylic acid
3-carboxypyridine
Acide Nicotinique
Acido nicotinico
Acidum Nicotinicum
Akotin
Anti-pellagra vitamin
Apelagrin
Daskil
Efacin
Enduracin
Linic
M-Pyridinecarboxylic Acid
Niac
Niacin
Niacine
Niacor
Niaspan
Niaspan ER
Nicacid
Nicamin
 
Nicangin
Nico-Span
Nicobid
Nicocap
Nicodelmine
Nicolar
Niconacid
Nicosan 3
Nicotinate
Nicotinic Acid
Nicotinic acid
Nicotinipca
Nicyl
Nikotinsaeure
Nyclin
P.P. factor
PP Factor
Pellagra preventive factor
Pellagrin
Pelonin
Pyridine-beta-carboxylic acid
Slo-niacin
Vitamin B3
Wampocap
beta-Pyridinecarboxylic acid
pyridine-β-carboxylic acid
β-pyridinecarboxylic acid
37
Folic Acidapproved, nutraceuticalPhase 2285159-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
38Omega-N-MethylargininePhase 2, Phase 154
39Vitamin B ComplexPhase 22775
40
ImidaprilPhase 2489371-37-95464343
Synonyms:
 
Imidapril hydrochloride
41Nicotinic AcidsPhase 2340
42Vitamin B3NutraceuticalPhase 2340
43FolateNutraceuticalPhase 22851
44
Nicotinamideexperimental, NutraceuticalPhase 233298-92-0936
Synonyms:
.beta.-Pyridinecarboxamide
11032-50-1
123574-63-0
1yc5
3 Pyridinecarboxamide
3-Carbamoylpyridine
3-Pyridinecarboxamide
3-Pyridinecarboxylic acid amide
37321-14-5
47865U_SUPELCO
55600-01-6
63748-44-7
72340_FLUKA
72340_SIGMA
72347_FLUKA
78731-47-2
98-92-0
A186B02E-6C70-4E54-9739-79398D439AAA
AC-907/25014114
AC1L1ACZ
AC1Q4ZFV
AI3-02906
Acid amide
Amid kyseliny nikotinove
Amid kyseliny nikotinove [Czech]
Amide PP
Aminicotin
Amixicotyn
Amnicotin
Astra Brand of Niacinamide
Austrovit PP
B 3, Vitamin
B3, Vitamin
BB_NC-2290
Benicot
C00153
C6H6N2O
CCRIS 1901
CHEBI:17154
CHEMBL1140
CID936
CPD000058212
D00036
D009536
DB02701
DEA No. 1405
Delonin Amide
Delonin amide
Dipegyl
Dipigyl
EINECS 202-713-4
EINECS 234-265-0
Endobion
Enduramide
Factor pp
HMS2052M21
HMS2090B05
HMS2093H03
HSDB 1237
Hansamid
I02-1741
I02-2250
InChI=1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9
Inovitan PP
Jenapharm Brand of Niacinamide
Jenapharm, Nicotinsaureamid
LS-2051
MLS000069714
Mediatric
Merck Brand of Niacinamide
MolMap_000061
MolPort-001-783-876
N0078
N0636_SIGMA
N2142_SIGMA
N3376_SIGMA
N5535_SIAL
NAM
NCGC00093354-03
NCGC00093354-04
NSC 13128
NSC13128
NSC27452
Nandervit-N
Niacevit
Niacinamide
Niacinamide (USP)
Niacinamide Astra Brand
Niacinamide Jenapharm Brand
Niacinamide Merck Brand
 
Niacinamide Pharmagenix Brand
Niacinamide [USAN]
Niacinamide, Nicotinic acid amide, Nicotinamide
Niacotinamide
Niamide
Niavit PP
Nicamide
Nicamina
Nicamindon
Nicasir
Nicobion
Nicofort
Nicogen
Nicomidol
Nicosan 2
Nicosylamide
Nicota
Nicotamide
Nicotilamide
Nicotililamido
Nicotinamid
Nicotinamida
Nicotinamida [INN-Spanish]
Nicotinamide
Nicotinamide (JP15/INN)
Nicotinamide (Niacinamide)
Nicotinamide, niacin, vitamin B3
Nicotinamide-carbonyl-14C
Nicotinamidum
Nicotinamidum [INN-Latin]
Nicotine acid amide
Nicotine amide
Nicotinic acid amide
Nicotinic amide
Nicotinsaeureamid
Nicotinsaureamid
Nicotinsaureamid Jenapharm
Nicotinsaureamid [German]
Nicotol
Nicotylamide
Nicotylamidum
Nicovel
Nicovit
Nicovitina
Nicovitol
Nicozymin
Nictoamide
Nikasan
Nikazan
Niko-tamin
Nikotinamid
Nikotinsaeureamid
Nikotinsaeureamid [German]
Niocinamide
Niozymin
PP-Faktor
Papulex
Pelmin
Pelmine
Pelonin amide
Pharmagenix Brand of Niacinamide
Propamine A
Pyridine-3-carboxylic acid amide
S1899_Selleck
SAM001246860
SGCUT00176
SMR000058212
Savacotyl
UNII-25X51I8RD4
Vi-Nicotyl
Vi-noctyl
Vitamin B
Vitamin B (VAN)
Vitamin B 3
Vitamin B3
Vitamin H1
Vitamin PP
WLN: T6NJ CVZ
Witamina PP
ZINC00005878
b-Pyridinecarboxamide
beta-Pyridinecarboxamide
bmse000281
m-(Aminocarbonyl)pyridine
nchembio.154-comp4
nchembio.73-comp6
niacin - Vitamin B3
niacinamide
nicotinamide
pyridine-3-carboxamide
to_000073
vitamin PP
45Vitamin B9NutraceuticalPhase 22851
46Bile Acids and SaltsPhase 180
47arginineNutraceuticalPhase 1346
48
MethyltestosteroneapprovedPhase 045358-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
17beta-Hydroxy-17-methylandrost-4-en-3-one
 
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methitest
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Testred C-III
Virilon
49
Letrozoleapproved, investigationalPhase 0326112809-51-53902
Synonyms:
1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole
1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole
112809-51-5
4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile
4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile
4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)
4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile
4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-Benzonitrile Letrozole
4,4'-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile
4,4'-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile
4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile
4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile
AB00514009
AC-1193
AC1L1GYT
AKOS005145822
BIDD:GT0015
BIDD:PXR0130
BPBio1_001331
BRD-K88789588-001-03-2
BSPBio_001209
Bio-0057
C067431
C08163
C17H11N5
CAS-112809-51-5
CCRIS 8822
CGS 20267
CGS 20267, Femara, Piroxicam, Letrozole
CGS-20267
CHEBI:6413
CHEMBL1444
CID3902
CPD000466343
D00964
 
DB01006
FEM-345
Femara
Femara (TN)
Femera
HMS1571M11
HMS2051E08
HMS2089L22
HSDB 7461
I06-0022
LS-38788
Letoval
Letrozol
Letrozole
Letrozole (JAN/USP/INN)
Letrozole [USAN:INN]
MLS000759455
MLS001424038
MLS002584991
MolPort-003-848-373
NCGC00016973-01
NCGC00016973-02
NSC719345
Novartis Brand of Letrozole
Prestwick0_001025
Prestwick1_001025
Prestwick2_001025
Prestwick3_001025
S1235_Selleck
SAM001246649
SMR000466343
SPBio_003070
TL8000371
UNII-7LKK855W8I
ZINC03778874
letrozole
50
Pioglitazoneapproved, investigationalPhase 0405111025-46-84829
Synonyms:
(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
(+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
(+/-)-5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione
(+/-)-5-[p-[2-(ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione
105355-27-9
111025-46-8
198077-89-3
2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]- (9CI)
5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione
5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione
5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione
5-[[4-[2-[(5-ethyl-2-pyridyl)]ethoxy]phenyl]methyl]thiazolidine- 2,4-dione
5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione
AB1004597
AC-1021
AC1L1J1Q
AD 4833
AD-4833
Actos
Actos (TN)
Actost
BRD-A48430263-003-02-4
BSPBio_002723
C07675
C19H20N2O3S
CHEBI:8228
CHEMBL595
CID4829
D08378
DB01132
Duetact
Glustin
HMS2089H14
HS-0047
 
HSDB 7322
I06-0089
KBio2_002103
KBio2_004671
KBio2_007239
KBio3_001943
KBioGR_001619
KBioSS_002103
LS-151327
MolPort-002-508-211
NCGC00163128-01
NCGC00163128-02
Pioglitazona
Pioglitazona [INN-Spanish]
Pioglitazone
Pioglitazone HCl
Pioglitazone Hydrochloride
Pioglitazone [BAN:INN]
Pioglitazone [Ban:Inn]
Pioglitazone [INN:BAN]
Pioglitazonum
Pioglitazonum [INN-Latin]
SPBio_001897
Spectrum2_001679
Spectrum3_001002
Spectrum4_001130
Spectrum5_001480
Spectrum5_002067
Spectrum_001623
U 72107
U 72107A
U-72107
U72,107A
UNII-X4OV71U42S
Zactos
nchembio790-comp10
pioglitazone (INN)
pioglitazone HCl

Interventional clinical trials:

(show top 50)    (show all 106)
idNameStatusNCT IDPhase
1Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT00414440Phase 4
2Weight Loss Improves Renal HemodynamicsCompletedNCT01356394Phase 4
3Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKDRecruitingNCT02494141Phase 4
4CCB Safety Study in Treatment of Hypertension of ADPKDNot yet recruitingNCT00541853Phase 4
5Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT00456365Phase 3
6Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT00346918Phase 3
7HALT Progression of Polycystic Kidney Disease (HALT PKD) Study BCompletedNCT01885559Phase 3
8HALT Progression of Polycystic Kidney Disease (HALT PKD) Study ACompletedNCT00283686Phase 3
9Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up StudyCompletedNCT00309283Phase 3
10A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]CompletedNCT01022424Phase 3
11A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan]CompletedNCT01280721Phase 3
12Tolvaptan Phase 3 Efficacy and Safety Study in ADPKDCompletedNCT00428948Phase 3
13Effects of Somatostatin on Liver in ADPKDCompletedNCT02119052Phase 2, Phase 3
14Effects of Somatostatin on ADPKD HeartCompletedNCT02119013Phase 2, Phase 3
15Lanreotide as Treatment of Polycystic LiversCompletedNCT00565097Phase 2, Phase 3
16Octreotide in Severe Polycystic Liver DiseaseCompletedNCT00426153Phase 2, Phase 3
17Efficacy and Safety of Tolvaptan in Cirrhotic Patients With HyponatremiaCompletedNCT01850940Phase 3
18Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver DiseaseCompletedNCT01315795Phase 2, Phase 3
19Lanreotide In Polycystic Kidney Disease StudyRecruitingNCT02127437Phase 3
20Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney DiseaseRecruitingNCT02055079Phase 3
21Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney DiseaseRecruitingNCT02160145Phase 3
22The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted RecipientsRecruitingNCT02134899Phase 3
23Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)RecruitingNCT02115659Phase 3
24Sirolimus for Massive Polycystic LiverRecruitingNCT01680250Phase 2, Phase 3
25Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)RecruitingNCT01733459Phase 3
26PCOS Treatment Using DLBS3233, Metformin, and Combination of BothRecruitingNCT01999686Phase 3
27Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal InsufficiencyActive, not recruitingNCT01377246Phase 3
28Study of Lanreotide to Treat Polycystic Kidney DiseaseActive, not recruitingNCT01616927Phase 3
29Open-Label Tolvaptan Study in Subjects With ADPKDActive, not recruitingNCT01214421Phase 3
30Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney DiseaseActive, not recruitingNCT02225860Phase 2, Phase 3
31Open-Label Extension of LOCKCYST TrialActive, not recruitingNCT00771888Phase 2, Phase 3
32Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney DiseaseEnrolling by invitationNCT02251275Phase 3
33Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal InsufficiencyTerminatedNCT01223755Phase 2, Phase 3
34Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarkers in Predicting a Response to TherapyTerminatedNCT00920309Phase 2, Phase 3
35Everolimus on CKD Progression in ADPKD PatientsTerminatedNCT01009957Phase 2, Phase 3
36Bosutinib For Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT01233869Phase 2
378-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT01451827Phase 2
38Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT00286156Phase 1, Phase 2
39A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]CompletedNCT00841568Phase 2
40Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKDCompletedNCT01210560Phase 2
41Short-Term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT01336972Phase 2
42Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and SafetyCompletedNCT00491517Phase 2
43Tolvaptan Open-Label Pilot Efficacy, Tolerability and Safety Study in ADPKDCompletedNCT00413777Phase 2
44Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)RecruitingNCT00890279Phase 2
45Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression ControlRecruitingNCT01932450Phase 2
46Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)RecruitingNCT02558595Phase 2
47Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain StudyRecruitingNCT00571909Phase 2
48Effect of the Aquaretic Tolvaptan on Nitric Oxide SystemRecruitingNCT02527863Phase 2
49Pasireotide LAR in Severe Polycystic Liver DiseaseRecruitingNCT01670110Phase 2
50Ursodeoxycholic Acid as Treatment for Polycystic Liver DiseaseRecruitingNCT02021110Phase 2

Search NIH Clinical Center for Polycystic Kidney Disease

Genetic Tests for Polycystic Kidney Disease

About this section

Anatomical Context for Polycystic Kidney Disease

About this section

MalaCards organs/tissues related to Polycystic Kidney Disease:

33
Kidney, Liver, Smooth muscle, Endothelial, Prostate, Bone, Testes

FMA organs/tissues related to Polycystic Kidney Disease:

16
The kidney

Animal Models for Polycystic Kidney Disease or affiliated genes

About this section

MGI Mouse Phenotypes related to Polycystic Kidney Disease:

38 (show all 11)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053888.5IFT88, INVS, MTOR, PKD1, PKD1L1, PKD2
2MP:00053708.4HNF1B, IFT88, INVS, PKD1, PKD2, PKHD1
3MP:00053858.4IFT88, INVS, NPHP3, PKD1, PKD1L1, PKD2
4MP:00053798.1HNF1B, IFT88, INVS, NEK1, PKD1, PKD2
5MP:00053807.8HNF1B, IFT88, INVS, MTOR, NPHP3, PKD1
6MP:00053977.7HAX1, INVS, MTOR, NEK1, NPHP3, PKD1
7MP:00036317.2HAX1, IFT88, MTOR, NEK1, NPHP3, PKD1
8MP:00053677.1HNF1B, IFT88, INVS, MTOR, NEK1, NPHP3
9MP:00053787.0HAX1, HNF1B, IFT88, INVS, MTOR, NEK1
10MP:00053766.9HNF1B, IFT88, INVS, MTOR, NEK1, NPHP3
11MP:00107686.7HAX1, HNF1B, IFT88, INVS, MTOR, NEK1

Publications for Polycystic Kidney Disease

About this section

Articles related to Polycystic Kidney Disease:

(show top 50)    (show all 1115)
idTitleAuthorsYear
1
Intragenic duplication in the PHKD1 gene in autosomal recessive polycystic kidney disease. (26502924)
2015
2
Autosomal dominant polycystic kidney disease: identification of two polymorphisms. (25847740)
2015
3
The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease. (25870008)
2015
4
Endovascular Treatment of Intracranial Aneurysms in Patients With Autosomal Dominant Polycystic Kidney Disease. (26492429)
2015
5
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease. (25961459)
2015
6
New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol. (26546139)
2015
7
Identification of Novel Glycans with Disialylated Structures in I+3 Integrin from Mouse Kidney Cells with the Phenotype of Polycystic Kidney Disease. (25300029)
2014
8
Vasopressin-2 receptor signaling and autosomal dominant polycystic kidney disease: from bench to bedside and back again. (24556353)
2014
9
Bilateral nephrectomy significantly improves health-related quality of life in a hemodialysis patient with autosomal dominant polycystic kidney disease. (24041611)
2013
10
Changing referral characteristics of patients with autosomal dominant polycystic kidney disease. (23830538)
2013
11
Complete staghorn calculus in polycystic kidney disease: infection is still the cause. (24070202)
2013
12
Multiple liver cyst infection caused by Salmonella ajiobo in autosomal dominant polycystic kidney disease. (23053500)
2013
13
Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis in autosomal dominant polycystic kidney disease. (23617397)
2013
14
Neutrophil-to-lymphocyte ratio, insulin resistance, and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease. (23580803)
2013
15
Polycystic kidney disease and chronic renal failure in tuberous sclerosis. (24092520)
2013
16
Bilateral papillary renal cell carcinoma and angiomyolipoma in the patients with autosomal dominant polycystic kidney disease: case report of two cases and literature review. (24375046)
2013
17
What is normal in an abnormality? Central venous cannulation in a patient with Situs inversus totalis with dextrocardia and polyCystic kidney disease. (24133338)
2013
18
Increasing extracellular matrix collagen level and MMP activity induces cyst development in polycystic kidney disease. (22963260)
2012
19
Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation. (21744088)
2012
20
A case of severe aortic valve regurgitation caused by an ascending aortic aneurysm in a young patient with autosomal dominant polycystic kidney disease and normal renal function. (22396705)
2012
21
Aquaretic treatment in polycystic kidney disease. (23121376)
2012
22
Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities. (23114901)
2012
23
Polycystic kidney disease presenting with hypertension and hypokalemia. (21962616)
2012
24
Insulin resistance and coronary flow velocity reserve in patients with autosomal dominant polycystic kidney disease. (21118411)
2012
25
The spectrum of polycystic kidney disease in children. (21896375)
2011
26
Incidental finding of autosomal dominant polycystic kidney disease with liver involvement on Tc-99m sestamibi scintigraphy. (21637047)
2011
27
WNT/I^-catenin signaling in polycystic kidney disease. (21720305)
2011
28
Autosomal dominant polycystic kidney disease (ADPKD) associated with steroid-sensitive nephrotic syndrome in childhood. (21116827)
2011
29
Disseminated hydatid disease mistaken for polycystic kidney disease by ultrasound. (21116276)
2010
30
Images in clinical medicine. Autosomal dominant polycystic kidney disease. (20592299)
2010
31
Spontaneous coronary artery dissection in a woman with polycystic kidney disease. (18992981)
2009
32
Glis3 is associated with primary cilia and Wwtr1/TAZ and implicated in polycystic kidney disease. (19273592)
2009
33
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. (18202196)
2008
34
Heightened epithelial Na+ channel-mediated Na+ absorption in a murine polycystic kidney disease model epithelium lacking apical monocilia. (16207792)
2006
35
From gene to disease; PKHD1 and recessive polycystic kidney disease]. (15771341)
2005
36
Molecular basis of autosomal dominant polycystic kidney disease. (15900113)
2005
37
The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1. (12500225)
2003
38
Morbidity from congenital hepatic fibrosis after renal transplantation for autosomal recessive polycystic kidney disease. (12118859)
2002
39
Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease. (11854326)
2002
40
A novel gene encoding a TIG multiple domain protein is a positional candidate for autosomal recessive polycystic kidney disease. (12079288)
2002
41
Mutation detection in the duplicated region of the polycystic kidney disease 1 (PKD1) gene in PKD1-linked Australian families. (11857740)
2002
42
Novel PKD1 deletions and missense variants in a cohort of Hellenic polycystic kidney disease families. (11571556)
2001
43
Autosomal dominant polycystic kidney disease: modification of disease progression. (11705510)
2001
44
Von Hippel-Lindau disease masquerading as autosomal dominant polycystic kidney disease. (11273887)
2001
45
cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. (10864573)
2000
46
A polycystic kidney-disease gene homologue required for male mating behaviour in C. elegans. (10517638)
1999
47
Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. (10023895)
1999
48
Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression. (9422539)
1998
49
The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances. (8957030)
1996
50
Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease. (1929024)
1991

Variations for Polycystic Kidney Disease

About this section

Expression for genes affiliated with Polycystic Kidney Disease

About this section
LifeMap Discovery
Genes differentially expressed in tissues of Polycystic Kidney Disease patients vs. healthy controls: 32 (show all 400)
id Gene Description Tissue Up/Dn Fold Change (log2) P value
1ALDOBaldolase B, fructose-bisphosphateKidney-10.060.000
2UMODuromodulinKidney-8.990.000
3PAHphenylalanine hydroxylaseKidney-8.600.000
4ALBalbuminKidney-8.460.000
5CALB1calbindin 1, 28kDaKidney-8.410.000
6NAT8N-acetyltransferase 8 (GCN5-related, putative)Kidney-8.170.000
7KNG1kininogen 1Kidney-7.940.000
8ACSM2Aacyl-CoA synthetase medium-chain family member 2AKidney-7.940.000
9GLYATL1glycine-N-acyltransferase-like 1Kidney-7.820.000
10GSTA1glutathione S-transferase alpha 1Kidney-7.820.000
11MFAP5microfibrillar associated protein 5Kidney+7.820.000
12DIO1deiodinase, iodothyronine, type IKidney-7.730.000
13MIOXmyo-inositol oxygenaseKidney-7.620.000
14DDCdopa decarboxylase (aromatic L-amino acid decarboxylase)Kidney-7.620.000
15ALDH8A1aldehyde dehydrogenase 8 family, member A1Kidney-7.580.000
16SLC17A3solute carrier family 17 (organic anion transporter), member 3Kidney-7.560.000
17SLC12A1solute carrier family 12 (sodium/potassium/chloride transporter), member 1Kidney-7.440.000
18SLC7A13solute carrier family 7 (anionic amino acid transporter), member 13Kidney-7.400.000
19DPYSdihydropyrimidinaseKidney-7.330.000
20SLC13A1solute carrier family 13 (sodium/sulfate symporter), member 1Kidney-7.300.000
21BBOX1butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1Kidney-7.260.000
22SFRP4secreted frizzled-related protein 4Kidney+7.250.000
23SLC7A9solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9Kidney-7.230.000
24GBA3glucosidase, beta, acid 3 (gene/pseudogene)Kidney-7.180.000
25HPD4-hydroxyphenylpyruvate dioxygenaseKidney-7.170.000
26SLC27A2solute carrier family 27 (fatty acid transporter), member 2Kidney-7.120.000
27TMEM27transmembrane protein 27Kidney-7.110.000
28HAO2hydroxyacid oxidase 2 (long chain)Kidney-7.030.000
29ACMSDaminocarboxymuconate semialdehyde decarboxylaseKidney-6.930.000
30PLGplasminogenKidney-6.900.000
31AZGP1alpha-2-glycoprotein 1, zinc-bindingKidney-6.880.000
32PCK1phosphoenolpyruvate carboxykinase 1 (soluble)Kidney-6.880.000
33MMEmembrane metallo-endopeptidaseKidney-6.850.000
34AGXT2alanine--glyoxylate aminotransferase 2Kidney-6.830.000
35GLYATglycine-N-acyltransferaseKidney-6.790.000
36SFRP2secreted frizzled-related protein 2Kidney+6.730.000
37UGT3A1UDP glycosyltransferase 3 family, polypeptide A1Kidney-6.730.000
38GDAguanine deaminaseKidney-6.680.000
39AFMafaminKidney-6.670.000
40G6PCglucose-6-phosphatase, catalytic subunitKidney-6.570.000
41XISTX inactive specific transcript (non-protein coding)Kidney+6.520.002
42CTXN3cortexin 3Kidney-6.500.000
43SCARA5scavenger receptor class A, member 5Kidney+6.440.000
44FGGfibrinogen gamma chainKidney+6.410.000
45CLRN3clarin 3Kidney-6.410.000
46CYP4A11cytochrome P450, family 4, subfamily A, polypeptide 11Kidney-6.410.000
47CTHRC1collagen triple helix repeat containing 1Kidney+6.410.000
48FMO1flavin containing monooxygenase 1Kidney-6.350.000
49TMEM174transmembrane protein 174Kidney-6.340.000
50SLC22A7solute carrier family 22 (organic anion transporter), member 7Kidney-6.320.000
51SLC6A13solute carrier family 6 (neurotransmitter transporter), member 13Kidney-6.300.000
52COMPcartilage oligomeric matrix proteinKidney+6.290.000
53SLC5A12solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12Kidney-6.280.000
54SMIM24small integral membrane protein 24Kidney-6.240.000
55RSPO3R-spondin 3Kidney+6.170.000
56HRGhistidine-rich glycoproteinKidney-6.140.000
57TINAGtubulointerstitial nephritis antigenKidney-6.140.000
58ITGBL1integrin, beta-like 1 (with EGF-like repeat domains)Kidney+6.120.000
59OMDosteomodulinKidney+6.110.000
60PRRX1paired related homeobox 1Kidney+6.100.000
61PDGFRLplatelet-derived growth factor receptor-likeKidney+6.080.000
62ACE2angiotensin I converting enzyme 2Kidney-6.060.000
63PIPOXpipecolic acid oxidaseKidney-6.030.000
64SLC3A1solute carrier family 3 (amino acid transporter heavy chain), member 1Kidney-6.010.000
65SLC2A2solute carrier family 2 (facilitated glucose transporter), member 2Kidney-5.990.000
66SLC26A7solute carrier family 26 (anion exchanger), member 7Kidney-5.950.000
67SLC17A1solute carrier family 17 (organic anion transporter), member 1Kidney-5.850.000
68TMEM52Btransmembrane protein 52BKidney-5.850.000
69PSAT1phosphoserine aminotransferase 1Kidney-5.830.000
70SLC34A1solute carrier family 34 (type II sodium/phosphate cotransporter), member 1Kidney-5.810.000
71CYP4F3cytochrome P450, family 4, subfamily F, polypeptide 3Kidney-5.800.000
72CYP27B1cytochrome P450, family 27, subfamily B, polypeptide 1Kidney-5.780.000
73RARRES1retinoic acid receptor responder (tazarotene induced) 1Kidney+5.740.000
74SLC16A9solute carrier family 16, member 9Kidney-5.730.000
75UGT2A3UDP glucuronosyltransferase 2 family, polypeptide A3Kidney-5.720.000
76SLC22A8solute carrier family 22 (organic anion transporter), member 8Kidney-5.700.000
77CUBNcubilin (intrinsic factor-cobalamin receptor)Kidney-5.700.000
78GREM1gremlin 1, DAN family BMP antagonistKidney+5.700.000
79ANGPTL3angiopoietin-like 3Kidney-5.700.000
80HGDhomogentisate 1,2-dioxygenaseKidney-5.690.000
81DCLK1doublecortin-like kinase 1Kidney+5.690.000
82FAM151Afamily with sequence similarity 151, member AKidney-5.670.000
83SLC22A6solute carrier family 22 (organic anion transporter), member 6Kidney-5.560.000
84DPEP1dipeptidase 1 (renal)Kidney-5.550.000
85TWIST2twist family bHLH transcription factor 2Kidney+5.500.000
86SLC47A1solute carrier family 47 (multidrug and toxin extrusion), member 1Kidney-5.490.000
87SLC47A2solute carrier family 47 (multidrug and toxin extrusion), member 2Kidney-5.490.000
88IL17RBinterleukin 17 receptor BKidney-5.470.000
89IGFBP6insulin-like growth factor binding protein 6Kidney+5.460.000
90SLC23A3solute carrier family 23, member 3Kidney-5.450.000
91SLPIsecretory leukocyte peptidase inhibitorKidney+5.440.000
92ABCC6ATP-binding cassette, sub-family C (CFTR/MRP), member 6Kidney-5.440.000
93SLCO4C1solute carrier organic anion transporter family, member 4C1Kidney-5.430.000
94DDX3YDEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linkedKidney-5.360.006
95EGFepidermal growth factorKidney-5.330.000
96CLDN2claudin 2Kidney-5.320.000
97SLC13A3solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3Kidney-5.320.000
98MKXmohawk homeoboxKidney+5.320.000
99TYRP1tyrosinase-related protein 1Kidney-5.310.000
100ENPP6ectonucleotide pyrophosphatase/phosphodiesterase 6Kidney-5.300.000
101AGMATagmatine ureohydrolase (agmatinase)Kidney-5.270.000
102TWIST1twist family bHLH transcription factor 1Kidney+5.260.000
103SMOC2SPARC related modular calcium binding 2Kidney+5.260.000
104RPS4Y1ribosomal protein S4, Y-linked 1Kidney-5.260.003
105COL6A2collagen, type VI, alpha 2Kidney+5.260.000
106UPP2uridine phosphorylase 2Kidney-5.250.000
107KCNJ15potassium channel, inwardly rectifying subfamily J, member 15Kidney-5.230.000
108DMGDHdimethylglycine dehydrogenaseKidney-5.220.000
109ADH6alcohol dehydrogenase 6 (class V)Kidney-5.220.000
110KCNJ1potassium channel, inwardly rectifying subfamily J, member 1Kidney-5.220.000
111CYP4A22cytochrome P450, family 4, subfamily A, polypeptide 22Kidney-5.210.000
112ATP6V0D2ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2Kidney-5.200.000
113ABAT4-aminobutyrate aminotransferaseKidney-5.190.000
114MGAMmaltase-glucoamylaseKidney-5.170.000
115FABP1fatty acid binding protein 1, liverKidney-5.170.000
116NPHS2nephrosis 2, idiopathic, steroid-resistant (podocin)Kidney-5.160.000
117UPB1ureidopropionase, betaKidney-5.160.000
118TMEM45Atransmembrane protein 45AKidney+5.140.000
119PLPPR1phospholipid phosphatase related 1Kidney-5.130.000
120SLC23A1solute carrier family 23 (ascorbic acid transporter), member 1Kidney-5.120.000
121CA2carbonic anhydrase IIKidney-5.090.000
122CLDN10claudin 10Kidney-5.070.000
123RENreninKidney-5.060.000
124GALNT15polypeptide N-acetylgalactosaminyltransferase 15Kidney+5.040.000
125PRLRprolactin receptorKidney-5.040.000
126ATP6V0A4ATPase, H+ transporting, lysosomal V0 subunit a4Kidney-5.030.000
127C3complement component 3Kidney+5.010.000
128PBLDphenazine biosynthesis-like protein domain containingKidney-5.010.000
129GATMglycine amidinotransferase (L-arginine:glycine amidinotransferase)Kidney-4.980.000
130COL11A1collagen, type XI, alpha 1Kidney+4.980.000
131AQP2aquaporin 2 (collecting duct)Kidney-4.960.000
132PTGISprostaglandin I2 (prostacyclin) synthaseKidney+4.950.000
133GSTT1glutathione S-transferase theta 1Kidney+4.950.000
134CFHcomplement factor HKidney+4.940.000
135SLC5A10solute carrier family 5 (sodium/sugar cotransporter), member 10Kidney-4.940.000
136APOMapolipoprotein MKidney-4.930.000
137GIPC2GIPC PDZ domain containing family, member 2Kidney-4.920.000
138FOXD1forkhead box D1Kidney+4.920.000
139CAPN3calpain 3Kidney-4.920.000
140OGNosteoglycinKidney+4.910.000
141RALYLRALY RNA binding protein-likeKidney-4.900.000
142LRRC19leucine rich repeat containing 19Kidney-4.890.000
143CYP4B1cytochrome P450, family 4, subfamily B, polypeptide 1Kidney+4.880.000
144AEBP1AE binding protein 1Kidney+4.870.000
145CYP8B1cytochrome P450, family 8, subfamily B, polypeptide 1Kidney-4.860.000
146FXYD2FXYD domain containing ion transport regulator 2Kidney-4.860.000
147DAPL1death associated protein-like 1Kidney+4.850.000
148SLC22A2solute carrier family 22 (organic cation transporter), member 2Kidney-4.830.000
149SCRG1stimulator of chondrogenesis 1Kidney+4.830.000
150OTOGLotogelin-likeKidney-4.820.000
151TMEM213transmembrane protein 213Kidney-4.820.000
152SLC4A4solute carrier family 4 (sodium bicarbonate cotransporter), member 4Kidney-4.820.000
153CYP4F2cytochrome P450, family 4, subfamily F, polypeptide 2Kidney-4.800.000
154PRELPproline/arginine-rich end leucine-rich repeat proteinKidney+4.780.000
155FCAMRFc receptor, IgA, IgM, high affinityKidney-4.780.000
156GKglycerol kinaseKidney-4.770.000
157AHNAK2AHNAK nucleoprotein 2Kidney+4.760.000
158A1CFAPOBEC1 complementation factorKidney-4.730.000
159CFDcomplement factor D (adipsin)Kidney+4.710.000
160AMDHD1amidohydrolase domain containing 1Kidney-4.710.000
161SORDsorbitol dehydrogenaseKidney-4.710.000
162SLC13A2solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2Kidney-4.710.000
163NAT8BN-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene)Kidney-4.700.000
164TMED6transmembrane p24 trafficking protein 6Kidney-4.690.000
165FOLH1folate hydrolase (prostate-specific membrane antigen) 1Kidney-4.690.000
166CCDC80coiled-coil domain containing 80Kidney+4.680.000
167KCNJ10potassium channel, inwardly rectifying subfamily J, member 10Kidney-4.670.000
168RNF212Bring finger protein 212BKidney-4.660.000
169SUCNR1succinate receptor 1Kidney-4.650.000
170MUC15mucin 15, cell surface associatedKidney-4.620.000
171SERPINA5serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5Kidney-4.610.000
172ADH1Balcohol dehydrogenase 1B (class I), beta polypeptideKidney+4.610.000
173SCG5secretogranin VKidney+4.600.000
174FOLH1Bfolate hydrolase 1BKidney-4.590.000
175CLUclusterinKidney+4.590.000
176SLC1A1solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1Kidney-4.590.000
177FHL1four and a half LIM domains 1Kidney+4.580.000
178CTSKcathepsin KKidney+4.580.000
179SLC6A19solute carrier family 6 (neutral amino acid transporter), member 19Kidney-4.570.000
180SLC10A2solute carrier family 10 (sodium/bile acid cotransporter), member 2Kidney-4.560.000
181FOLR1folate receptor 1 (adult)Kidney-4.530.000
182SDC1syndecan 1Kidney-4.530.000
183FBLN1fibulin 1Kidney+4.530.000
184C9orf66chromosome 9 open reading frame 66Kidney-4.520.000
185TMEM130transmembrane protein 130Kidney+4.520.000
186FREM2FRAS1 related extracellular matrix protein 2Kidney-4.520.000
187COL8A1collagen, type VIII, alpha 1Kidney+4.500.000
188NNMTnicotinamide N-methyltransferaseKidney+4.500.000
189C1Rcomplement component 1, r subcomponentKidney+4.500.000
190MMP3matrix metallopeptidase 3Kidney+4.490.013
191KLklothoKidney-4.490.000
192APOHapolipoprotein H (beta-2-glycoprotein I)Kidney-4.490.000
193OGDHLoxoglutarate dehydrogenase-likeKidney-4.490.000
194IL13RA2interleukin 13 receptor, alpha 2Kidney-4.480.000
195VGLL3vestigial-like family member 3Kidney+4.480.000
196BHLHE41basic helix-loop-helix family, member e41Kidney+4.480.000
197GGACTgamma-glutamylamine cyclotransferaseKidney-4.470.000
198APOEapolipoprotein EKidney-4.460.000
199SLC2A3solute carrier family 2 (facilitated glucose transporter), member 3Kidney+4.450.000
200FBP1fructose-1,6-bisphosphatase 1Kidney-4.450.000
201QPRTquinolinate phosphoribosyltransferaseKidney-4.450.000
202IGF1insulin-like growth factor 1 (somatomedin C)Kidney+4.450.000
203LAMA4laminin, alpha 4Kidney+4.440.000
204FMODfibromodulinKidney+4.440.000
205COL1A2collagen, type I, alpha 2Kidney+4.430.000
206LGALS2lectin, galactoside-binding, soluble, 2Kidney-4.420.000
207COL12A1collagen, type XII, alpha 1Kidney+4.420.000
208FAM129Afamily with sequence similarity 129, member AKidney+4.410.000
209VCANversicanKidney+4.410.000
210PDLIM3PDZ and LIM domain 3Kidney+4.410.000
211TNCtenascin CKidney+4.380.000
212GXYLT2glucoside xylosyltransferase 2Kidney+4.370.000
213MAMDC2MAM domain containing 2Kidney+4.370.000
214ZFPM2zinc finger protein, FOG family member 2Kidney+4.370.000
215ACPPacid phosphatase, prostateKidney-4.370.000
216SRPXsushi-repeat containing protein, X-linkedKidney+4.360.000
217EVA1Ceva-1 homolog C (C. elegans)Kidney+4.360.000
218KCNT2potassium channel, sodium activated subfamily T, member 2Kidney+4.360.000
219CLEC18AC-type lectin domain family 18, member AKidney-4.360.000
220CYP17A1cytochrome P450, family 17, subfamily A, polypeptide 1Kidney-4.350.000
221SOSTsclerostinKidney-4.350.000
222CNN1calponin 1, basic, smooth muscleKidney+4.340.000
223USH1CUsher syndrome 1CKidney-4.330.000
224TPM2tropomyosin 2 (beta)Kidney+4.320.000
225FLJ22763uncharacterized LOC401081Kidney-4.320.000
226NAMPTnicotinamide phosphoribosyltransferaseKidney+4.320.000
227PTX3pentraxin 3, longKidney+4.320.012
228GPR37G protein-coupled receptor 37 (endothelin receptor type B-like)Kidney+4.300.000
229HEPACAM2HEPACAM family member 2Kidney-4.280.000
230PAQR5progestin and adipoQ receptor family member VKidney-4.280.000
231SCNN1Gsodium channel, non voltage gated 1 gamma subunitKidney-4.280.000
232HNF4Ghepatocyte nuclear factor 4, gammaKidney-4.280.000
233BHMTbetaine--homocysteine S-methyltransferaseKidney-4.280.001
234SOCS3suppressor of cytokine signaling 3Kidney+4.270.000
235PLA2G2Aphospholipase A2, group IIA (platelets, synovial fluid)Kidney+4.270.002
236MAP7D2MAP7 domain containing 2Kidney-4.270.000
237CPEcarboxypeptidase EKidney+4.270.000
238COLEC11collectin sub-family member 11Kidney-4.260.000
239CNR1cannabinoid receptor 1 (brain)Kidney+4.260.000
240CLDN8claudin 8Kidney-4.250.004
241CEACAM1carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)Kidney-4.250.000
242DEPDC7DEP domain containing 7Kidney-4.250.000
243LOC149703uncharacterized LOC149703Kidney-4.250.000
244TRPM3transient receptor potential cation channel, subfamily M, member 3Kidney-4.240.000
245NOVnephroblastoma overexpressedKidney+4.240.000
246PDZRN4PDZ domain containing ring finger 4Kidney+4.230.000
247MAP3K8mitogen-activated protein kinase kinase kinase 8Kidney+4.200.000
248METTL7Bmethyltransferase like 7BKidney-4.200.000
249SYNPO2synaptopodin 2Kidney+4.200.000
250DAOD-amino-acid oxidaseKidney-4.200.000
251TFCP2L1transcription factor CP2-like 1Kidney-4.200.000
252SERPINA3serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3Kidney+4.190.000
253UNC5CLunc-5 family C-terminal likeKidney-4.180.000
254EHHADHenoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenaseKidney-4.180.000
255ARG2arginase 2Kidney-4.180.001
256CR2complement component (3d/Epstein Barr virus) receptor 2Kidney-4.170.000
257CLCNKBchloride channel, voltage-sensitive KbKidney-4.140.000
258VAV3vav 3 guanine nucleotide exchange factorKidney-4.140.000
259EIF1AYeukaryotic translation initiation factor 1A, Y-linkedKidney-4.140.005
260WISP2WNT1 inducible signaling pathway protein 2Kidney+4.130.000
261TAC1tachykinin, precursor 1Kidney+4.130.000
262CRHBPcorticotropin releasing hormone binding proteinKidney-4.120.000
263CXCL1chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)Kidney+4.120.001
264RBP5retinol binding protein 5, cellularKidney-4.120.000
265NTMneurotriminKidney+4.110.000
266HSD11B2hydroxysteroid (11-beta) dehydrogenase 2Kidney-4.110.000
267KHKketohexokinase (fructokinase)Kidney-4.100.000
268ALDH6A1aldehyde dehydrogenase 6 family, member A1Kidney-4.100.000
269LOXlysyl oxidaseKidney+4.100.000
270SLITRK5SLIT and NTRK-like family, member 5Kidney+4.100.000
271GCgroup-specific component (vitamin D binding protein)Kidney-4.090.000
272TFECtranscription factor ECKidney-4.090.000
273H19H19, imprinted maternally expressed transcript (non-protein coding)Kidney+4.080.000
274PRODH2proline dehydrogenase (oxidase) 2Kidney-4.080.000
275LOC284578uncharacterized LOC284578Kidney-4.080.000
276SLC7A7solute carrier family 7 (amino acid transporter light chain, y+L system), member 7Kidney-4.080.000
277CPceruloplasmin (ferroxidase)Kidney+4.080.002
278KMOkynurenine 3-monooxygenase (kynurenine 3-hydroxylase)Kidney-4.060.000
279MYH11myosin, heavy chain 11, smooth muscleKidney+4.060.000
280WDR72WD repeat domain 72Kidney-4.050.000
281C10orf10chromosome 10 open reading frame 10Kidney+4.040.000
282OSR2odd-skipped related transciption factor 2Kidney+4.040.000
283FBN1fibrillin 1Kidney+4.040.000
284HOGA14-hydroxy-2-oxoglutarate aldolase 1Kidney-4.030.000
285RDH12retinol dehydrogenase 12 (all-trans/9-cis/11-cis)Kidney-4.020.000
286GGT1gamma-glutamyltransferase 1Kidney-4.020.000
287SLC22A11solute carrier family 22 (organic anion/urate transporter), member 11Kidney-4.010.000
288EMCNendomucinKidney-4.000.005
289HRH1histamine receptor H1Kidney+3.990.000
290SERPINF1serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1Kidney+3.990.000
291FXYD4FXYD domain containing ion transport regulator 4Kidney-3.980.000
292LRRN4CLLRRN4 C-terminal likeKidney+3.980.000
293ENPEPglutamyl aminopeptidase (aminopeptidase A)Kidney-3.980.000
294DKK2dickkopf WNT signaling pathway inhibitor 2Kidney+3.970.000
295ISLRimmunoglobulin superfamily containing leucine-rich repeatKidney+3.960.000
296XPNPEP2X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-boundKidney-3.960.000
297COL8A2collagen, type VIII, alpha 2Kidney+3.960.000
298ERBB3erb-b2 receptor tyrosine kinase 3Kidney-3.960.000
299DAB2Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)Kidney-3.940.000
300SRPX2sushi-repeat containing protein, X-linked 2Kidney+3.940.000
301NAPSAnapsin A aspartic peptidaseKidney-3.930.000
302MAPTmicrotubule-associated protein tauKidney-3.930.000
303THBS2thrombospondin 2Kidney+3.920.000
304DKK3dickkopf WNT signaling pathway inhibitor 3Kidney+3.920.000
305HILPDAhypoxia inducible lipid droplet-associatedKidney+3.910.032
306DHRS2dehydrogenase/reductase (SDR family) member 2Kidney+3.890.012
307MAP1Bmicrotubule-associated protein 1BKidney+3.890.000
308CAV1caveolin 1, caveolae protein, 22kDaKidney+3.890.000
309ADGRL3adhesion G protein-coupled receptor L3Kidney+3.880.001
310COL1A1collagen, type I, alpha 1Kidney+3.880.002
311DPYSL3dihydropyrimidinase-like 3Kidney+3.870.000
312COL6A3collagen, type VI, alpha 3Kidney+3.870.000
313PNOCprepronociceptinKidney+3.870.000
314PTGFRNprostaglandin F2 receptor inhibitorKidney+3.850.000
315INHBAinhibin, beta AKidney+3.840.000
316ADGRD1adhesion G protein-coupled receptor D1Kidney+3.840.000
317ACTG2actin, gamma 2, smooth muscle, entericKidney+3.830.001
318MSLNmesothelinKidney+3.830.000
319ADAMTS15ADAM metallopeptidase with thrombospondin type 1 motif, 15Kidney+3.820.000
320FSTfollistatinKidney+3.820.000
321CCDC3coiled-coil domain containing 3Kidney+3.820.000
322NALCNsodium leak channel, non selectiveKidney+3.810.000
323MN1meningioma (disrupted in balanced translocation) 1Kidney+3.790.000
324PROCRprotein C receptor, endothelialKidney+3.790.000
325CCND2cyclin D2Kidney+3.790.000
326NID2nidogen 2 (osteonidogen)Kidney+3.770.000
327CDONcell adhesion associated, oncogene regulatedKidney+3.750.000
328PCSK5proprotein convertase subtilisin/kexin type 5Kidney+3.740.000
329ADGRG2adhesion G protein-coupled receptor G2Kidney+3.740.000
330C1RLcomplement component 1, r subcomponent-likeKidney+3.730.000
331KCNE4potassium channel, voltage gated subfamily E regulatory beta subunit 4Kidney+3.710.000
332PPP1R3Cprotein phosphatase 1, regulatory subunit 3CKidney+3.700.000
333LAMP5lysosomal-associated membrane protein family, member 5Kidney+3.700.001
334ALDH1L2aldehyde dehydrogenase 1 family, member L2Kidney+3.700.000
335ACKR3atypical chemokine receptor 3Kidney+3.690.000
336FBLN2fibulin 2Kidney+3.680.000
337LY96lymphocyte antigen 96Kidney+3.680.000
338PCDH7protocadherin 7Kidney+3.660.000
339C1Scomplement component 1, s subcomponentKidney+3.660.001
340APODapolipoprotein DKidney+3.660.001
341C19orf33chromosome 19 open reading frame 33Kidney+3.650.000
342CNKSR2connector enhancer of kinase suppressor of Ras 2Kidney+3.650.000
343NFKBIZnuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zetaKidney+3.640.000
344ANXA1annexin A1Kidney+3.640.000
345FABP4fatty acid binding protein 4, adipocyteKidney+3.630.003
346GLT8D2glycosyltransferase 8 domain containing 2Kidney+3.630.000
347TIMP1TIMP metallopeptidase inhibitor 1Kidney+3.620.000
348FABP5fatty acid binding protein 5 (psoriasis-associated)Kidney+3.620.000
349PCOLCEprocollagen C-endopeptidase enhancerKidney+3.620.000
350MSRB3methionine sulfoxide reductase B3Kidney+3.620.000
351TAGLNtransgelinKidney+3.610.000
352PDLIM4PDZ and LIM domain 4Kidney+3.580.000
353MEOX2mesenchyme homeobox 2Kidney+3.580.000
354CDC42EP5CDC42 effector protein (Rho GTPase binding) 5Kidney+3.570.000
355EFSembryonal Fyn-associated substrateKidney+3.550.000
356SPON1spondin 1, extracellular matrix proteinKidney+3.550.000
357HLA-DQB1major histocompatibility complex, class II, DQ beta 1Kidney+3.550.000
358HTR2B5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupledKidney+3.550.000
359DPTdermatopontinKidney+3.540.003
360FAPfibroblast activation protein, alphaKidney+3.520.000
361SERTM1serine-rich and transmembrane domain containing 1Kidney+3.510.000
362PAMR1peptidase domain containing associated with muscle regeneration 1Kidney+3.510.000
363CRLF1cytokine receptor-like factor 1Kidney+3.510.002
364PROSER2proline and serine rich 2Kidney+3.510.000
365LMOD1leiomodin 1 (smooth muscle)Kidney+3.500.000
366SLC25A37solute carrier family 25 (mitochondrial iron transporter), member 37Kidney+3.490.000
367NEXNnexilin (F actin binding protein)Kidney+3.490.000
368MYCv-myc avian myelocytomatosis viral oncogene homologKidney+3.460.000
369CILPcartilage intermediate layer protein, nucleotide pyrophosphohydrolaseKidney+3.450.018
370FGF18fibroblast growth factor 18Kidney+3.450.000
371MYL9myosin, light chain 9, regulatoryKidney+3.450.000
372MEDAGmesenteric estrogen-dependent adipogenesisKidney+3.450.000
373BEND6BEN domain containing 6Kidney+3.440.000
374LPAR1lysophosphatidic acid receptor 1Kidney+3.440.000
375LOXL1lysyl oxidase-like 1Kidney+3.430.000
376BOCBOC cell adhesion associated, oncogene regulatedKidney+3.430.000
377CXCL2chemokine (C-X-C motif) ligand 2Kidney+3.410.006
378CCDC109Bcoiled-coil domain containing 109BKidney+3.410.000
379RASSF2Ras association (RalGDS/AF-6) domain family member 2Kidney+3.400.000
380CLDN11claudin 11Kidney+3.390.011
381COL5A2collagen, type V, alpha 2Kidney+3.390.001
382C1QTNF7C1q and tumor necrosis factor related protein 7Kidney+3.390.000
383ARHGAP20Rho GTPase activating protein 20Kidney+3.390.000
384DMDdystrophinKidney+3.370.000
385PTPRZ1protein tyrosine phosphatase, receptor-type, Z polypeptide 1Kidney+3.370.008
386BMP7bone morphogenetic protein 7Kidney+3.360.000
387PPP1R14Aprotein phosphatase 1, regulatory (inhibitor) subunit 14AKidney+3.360.000
388ACTA2actin, alpha 2, smooth muscle, aortaKidney+3.360.000
389KIAA0226LKIAA0226-likeKidney+3.360.000
390CDO1cysteine dioxygenase type 1Kidney+3.360.000
391COL3A1collagen, type III, alpha 1Kidney+3.360.001
392ANKDD1Aankyrin repeat and death domain containing 1AKidney+3.350.000
393MGPmatrix Gla proteinKidney+3.340.000
394CSTAcystatin A (stefin A)Kidney+3.330.000
395CXCL8chemokine (C-X-C motif) ligand 8Kidney+3.330.011
396LTBP1latent transforming growth factor beta binding protein 1Kidney+3.320.000
397GRK5G protein-coupled receptor kinase 5Kidney+3.320.000
398IL17Dinterleukin 17DKidney+3.310.000
399MCAMmelanoma cell adhesion moleculeKidney+3.310.000
400ANKRD36ankyrin repeat domain 36Kidney+3.300.000

Search GEO for disease gene expression data for Polycystic Kidney Disease.

Pathways for genes affiliated with Polycystic Kidney Disease

About this section

GO Terms for genes affiliated with Polycystic Kidney Disease

About this section

Cellular components related to Polycystic Kidney Disease according to GeneCards Suite gene sharing:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1polycystin complexGO:000213310.8PKD1, PKD2
2cation channel complexGO:003470310.7PKD1L3, PKD2L1
3motile primary ciliumGO:003151210.6IFT88, PKD1, PKD2
4ciliary inversin compartmentGO:009754310.5INVS, NPHP3
5nonmotile primary ciliumGO:003151310.5PKD1L1, PKD2, PKD2L1
6TSC1-TSC2 complexGO:003359610.4TSC1, TSC2
7ciliary membraneGO:006017010.3PKD1, PKD1L1, PKD2, PKD2L1
8ciliary basal bodyGO:003606410.3IFT88, PKD2, PKHD1
9ciliary baseGO:009754610.2IFT88, INVS, NPHP3
10primary ciliumGO:007237210.1IFT88, NPHP3, PKD1, PKHD1
11ciliumGO:00059299.4IFT88, NPHP3, PKD1, PKD1L1, PKD2
12membraneGO:00160207.4INVS, MTOR, PKD1, PKD1L1, PKD1L2, PKD1L3

Biological processes related to Polycystic Kidney Disease according to GeneCards Suite gene sharing:

(show all 27)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycleGO:003165910.8PKD1, PKD2
2placenta blood vessel developmentGO:006067410.7PKD1, PKD2
3detection of nodal flowGO:000312710.7PKD1L1, PKD2
4cytoplasmic sequestering of transcription factorGO:004299410.7PKD1, PKD2
5response to fluid shear stressGO:003440510.7IFT88, PKD1
6detection of chemical stimulus involved in sensory perception of sour tasteGO:000158110.7PKD1L3, PKD2L1
7sensory perception of sour tasteGO:005091510.7PKD1L3, PKD2L1
8cellular response to acidic pHGO:007146810.7PKD1L3, PKD2L1
9metanephric ascending thin limb developmentGO:007221810.7PKD1, PKD2
10renal system developmentGO:007200110.4PKD1, PKD2, PRKCSH
11mesonephric tubule developmentGO:007216410.4HNF1B, PKD1, PKD2
12determination of liver left/right asymmetryGO:007191010.4NPHP3, PKD2
13nitrogen compound metabolic processGO:000680710.3PKD1, PRKCSH
14mesonephric duct developmentGO:007217710.3HNF1B, PKD1, PKD2
15kidney morphogenesisGO:006099310.3HNF1B, NPHP3
16cilium assemblyGO:004238410.2IFT88, NEK1, PKHD1
17negative regulation of cell sizeGO:004579210.1MTOR, TSC1
18genitalia developmentGO:004880610.1HNF1B, PKD1
19single organismal cell-cell adhesionGO:001633710.0PKD1, PKD1L1, PKHD1
20regulation of cAMP metabolic processGO:003081410.0NPHP3, PKD2
21determination of left/right symmetryGO:00073689.7IFT88, NPHP3, PKD2
22liver developmentGO:00018899.6HNF1B, IFT88, PKD1, PKD2, PRKCSH
23heart developmentGO:00075079.3IFT88, PKD1, PKD2, TSC2
24cell cycle arrestGO:00070509.2MTOR, PKD1, PKD2, TSC1, TSC2
25detection of mechanical stimulusGO:00509829.1PKD1, PKD1L1, PKD1L2, PKD2, PKD2L1, PKD2L2
26calcium ion transmembrane transportGO:00705888.8PKD1, PKD1L1, PKD1L2, PKD1L3, PKD2, PKD2L1
27kidney developmentGO:00018227.9HNF1B, IFT88, INVS, NEK1, NPHP3, PKD1

Molecular functions related to Polycystic Kidney Disease according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1muscle alpha-actinin bindingGO:005137110.8PKD2, PKD2L1
2sour taste receptor activityGO:003304010.8PKD1L3, PKD2L1
3alpha-actinin bindingGO:005139310.8PKD2, PKD2L1
4cation transmembrane transporter activityGO:000832410.7PKD1L3, PKD2L1
5ion channel bindingGO:004432510.4PKD1, PKD2, PRKCSH
6phosphoprotein bindingGO:005121910.0MTOR, PKD2, PRKCSH
7calcium ion bindingGO:00055099.4PKD1L2, PKD2, PKD2L1, PKD2L2, PKDREJ, PRKCSH
8calcium channel activityGO:00052629.4PKD1, PKD1L1, PKD1L2, PKD1L3, PKD2L1, PKD2L2
9protein bindingGO:00055155.7HAX1, HNF1B, IFT88, INVS, MTOR, NEK1

Sources for Polycystic Kidney Disease

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet